<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?subarticle pone.0239054.r001?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7489565</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0239054</article-id><article-id pub-id-type="publisher-id">PONE-D-20-10863</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biosynthesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biocatalysis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Catalysis</subject><subj-group><subject>Biocatalysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Biotechnology</subject><subj-group><subject>Applied Microbiology</subject><subj-group><subject>Industrial Microbiology</subject><subj-group><subject>Biocatalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Biotechnology</subject><subj-group><subject>Applied Microbiology</subject><subj-group><subject>Industrial Microbiology</subject><subj-group><subject>Biocatalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Applied Microbiology</subject><subj-group><subject>Industrial Microbiology</subject><subj-group><subject>Biocatalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Alignment</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Post-Translational Modification</subject><subj-group><subject>Hydroxylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Streptomyces</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Streptomyces</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Streptomyces</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Actinomadura</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Actinomadura</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Actinomadura</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic</article-title><alt-title alt-title-type="running-head">The biosynthetic pathway to tetromadurin (SF2487/A80577)</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4279-1405</contrib-id><name><surname>Little</surname><given-names>Rory F.</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Funding acquisition</role><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Validation</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="author-notes" rid="currentaff001"><sup>&#x000a4;</sup></xref><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Samborskyy</surname><given-names>Markiyan</given-names></name><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Software</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Leadlay</surname><given-names>Peter F.</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Funding acquisition</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Resources</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Validation</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Cirino</surname><given-names>Patrick C.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Houston, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="current-aff" id="currentaff001"><label>&#x000a4;</label><p>Current address: Leibniz Institute of Natural Products Research and Infection Biology, Jena, Germany</p></fn><corresp id="cor001">* E-mail: <email>rory.little@leibniz-hki.de</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>9</issue><elocation-id>e0239054</elocation-id><history><date date-type="received"><day>15</day><month>4</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Little et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Little et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0239054.pdf"/><abstract><p>The type I polyketide SF2487/A80577 (herein referred to as tetromadurin) is a polyether tetronate ionophore antibiotic produced by the terrestrial Gram-positive bacterium <italic>Actinomadura verrucosospora</italic>. Tetromadurin is closely related to the polyether tetronates tetronasin (M139603) and tetronomycin, all of which are characterised by containing a tetronate, cyclohexane, tetrahydropyran, and at least one tetrahydrofuran ring. We have sequenced the genome of <italic>Actinomadura verrucosospora</italic> to identify the biosynthetic gene cluster responsible for tetromadurin biosynthesis (the <italic>mad</italic> gene cluster). Based on bioinformatic analysis of the 32 genes present within the cluster a plausible biosynthetic pathway for tetromadurin biosynthesis is proposed. Functional confirmation of the <italic>mad</italic> gene cluster is obtained by performing in-frame deletions in each of the genes <italic>mad10</italic> and <italic>mad31</italic>, which encode putative cyclase enzymes responsible for cyclohexane and tetrahydropyran formation, respectively. Furthermore, the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant produces a novel tetromadurin metabolite that according to mass spectrometry analysis is analogous to the recently characterised partially cyclised tetronasin intermediate lacking its cyclohexane and tetrahydropyran rings. Our results therefore elucidate the biosynthetic machinery of tetromadurin biosynthesis and lend support for a conserved mechanism of cyclohexane and tetrahydropyran biosynthesis across polyether tetronates.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Woolf Fisher Trust</institution></funding-source><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4279-1405</contrib-id><name><surname>Little</surname><given-names>Rory F.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003343</institution-id><institution>Cambridge Commonwealth, European and International Trust</institution></institution-wrap></funding-source><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4279-1405</contrib-id><name><surname>Little</surname><given-names>Rory F.</given-names></name></principal-award-recipient></award-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="9"/><table-count count="3"/><page-count count="26"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files. The genome sequence of A. verrucosospora has been deposited on GenBank (Accession number: CP053892).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files. The genome sequence of A. verrucosospora has been deposited on GenBank (Accession number: CP053892).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>SF2487/A80577 (<bold>1</bold>) (referred to in this manuscript as tetromadurin) is a type I polyketide polyether tetronate isolated independently from <italic>Actinomadura verrucosospora</italic> by two industrial research groups in the early 1990s [<xref rid="pone.0239054.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0239054.ref002" ref-type="bibr">2</xref>] (<bold><xref ref-type="fig" rid="pone.0239054.g001">Fig 1</xref></bold>). It belongs to the same family of polyether tetronates as tetronasin (<bold>2</bold>) (produced by <italic>Streptomyces longisporoflavus</italic>) and tetronomycin (<bold>3</bold>) (produced by <italic>Streptomyces</italic> sp. NRRL 11266), which are all characterised by containing a tetronate, cyclohexane, tetrahydropyran, and at least one tetrahydrofuran ring (<bold><xref ref-type="fig" rid="pone.0239054.g001">Fig 1</xref></bold>). Tetronasin and tetronomycin are notable for being near- &#x0201c;mirror image&#x0201d; versions of one another, containing the opposite configuration at each of ten equivalent stereocenters. Tetromadurin contains structural elements of each, its cyclohexane and tetrahydropyran rings of tetromadurin having identical configuration to those in tetronasin, while its tetronate ring contains a tetronomycin-like exocyclic double bond. All three compounds, like other polyethers such as monensin, are ionophore antibiotics that disrupt ion signalling across cell membranes [<xref rid="pone.0239054.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0239054.ref003" ref-type="bibr">3</xref>&#x02013;<xref rid="pone.0239054.ref005" ref-type="bibr">5</xref>]. In addition, tetromadurin has also demonstrated antiretroviral and antimalarial activity [<xref rid="pone.0239054.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0239054.ref006" ref-type="bibr">6</xref>].</p><fig id="pone.0239054.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g001</object-id><label>Fig 1</label><caption><title>The polyether tetronates tetromadurin (1), tetronasin (2), and tetronomycin (3).</title></caption><graphic xlink:href="pone.0239054.g001"/></fig><p>The high degree of structural similarity between tetromadurin and tetronasin/tetronomycin suggests a similar biosynthetic pathway for its biosynthesis. The biosynthetic gene clusters (BGCs) responsible for the production of tetronasin (the <italic>tsn</italic> gene cluster) and tetronomycin (the <italic>tmn</italic> gene cluster) have both been sequenced (Genbank: FJ462704 and AB193609, respectively) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]. The <italic>tsn</italic> and <italic>tmn</italic> gene clusters both encode five type I polyketide synthase (PKS) enzymes that condense six (<italic>2S</italic>)-methylmalonyl-CoA and seven malonyl-CoA extension units to form the 26 carbon skeletons of tetronasin and tetronomycin. In addition, both gene clusters also encode enzymes for creation of the four ring types, an <italic>O</italic>-methyltransferase for the C26 methoxy group, and a cyctochrome P450 for the primary hydroxyl group (C30 in tetronasin <bold>2</bold> and C28 in tetronomycin <bold>3</bold>) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]. In contrast, on the basis of its structure we predicted that the 31-carbon polyketide skeleton of tetromadurin is synthesised using six malonyl-CoA, eight (<italic>2S</italic>)-methylmalonyl-CoA, and one uncommon (<italic>2R</italic>)-methoxymalonyl-ACP (acyl-carrier protein) unit (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s001">S1 Fig</xref></bold>). Also, unlike tetronasin and tetronomycin, tetromadurin contains two primary hydroxyl groups (positions C36 and C38) and two tetrahydrofuran rings.</p><p>We have performed whole-genome sequencing of <italic>A</italic>. <italic>verrucosospora</italic> to identify the biosynthetic gene cluster responsible for tetromadurin biosynthesis (the <italic>mad</italic> gene cluster). Bioinformatic analysis of the individual genes within the <italic>mad</italic> gene cluster enabled us to propose a complete pathway for tetromadurin biosynthesis. Furthermore, the PKS enzymes encoded by the <italic>mad</italic> gene cluster indicate an unusual case where one of the ketoreductase (KR) domains appears to act externally from its parent module. To functionally validate the <italic>mad</italic> gene cluster, independent in-frame deletions were made in the putative cyclase genes <italic>mad10</italic> and <italic>mad31</italic>. Deletion of either of these genes abolished tetromadurin production. In addition, mass spectrometry analysis of the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant indicated the production of a late-stage tetromadurin biosynthetic intermediate lacking the cyclohexane and tetrahydropyran rings and one primary hydroxyl group, analogous to the intermediate recently characterised from a <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 mutant [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Taken together, our findings clarify several aspects of tetromadurin biosynthesis, including identifying its biosynthetic gene cluster (BGC), determining the relative order of the two cytochrome P450-catalyzed hydroxylations, and supporting a conserved mechanism of cyclohexane and tetrahydropyran formation in polyether tetronate biosynthesis.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Oligonucleotides, plasmids, and bacterial strains</title><p>All oligonucleotide primers were synthesised by Sigma-Aldrich and are presented in <bold><xref rid="pone.0239054.t001" ref-type="table">Table 1</xref></bold>. The plasmids and bacteria strains used/created in this study are presented in <bold>Tables <xref rid="pone.0239054.t002" ref-type="table">2</xref></bold> and <bold><xref rid="pone.0239054.t003" ref-type="table">3</xref></bold>, respectively.</p><table-wrap id="pone.0239054.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.t001</object-id><label>Table 1</label><caption><title>Primers used in this study.</title></caption><alternatives><graphic id="pone.0239054.t001g" xlink:href="pone.0239054.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Primer</th><th align="left" rowspan="1" colspan="1">Sequence (5&#x02019;-3&#x02019;)</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1"><italic>Primers used for creating pYH7 gene deletion constructs</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_Up_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACTGATCAAGGCGAATACTTCAGCCGAGCTGCTGCTGGAACTGCTGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_Up_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GCGGCGCGCGACGCGGCGCCGACGCGGTCATGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_Dn_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GCGTCGGCGCCGCGTCGCGCGCCGCAGCC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_Dn_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACCCGCGCGGTCGATCCCCGCACTTGATCAGGCCGGTGATGCCGGCC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_Up_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACTGATCAAGGCGAATACTTCACCGGCAGCGGCGGAAGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_Up_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>CGACGATGTAGATCGGCGACACGCCGG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_Dn_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GGCGTGTCGCCGATCTACATCGTCGGAACGGG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_Dn_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACCCGCGCGGTCGATCCCCGCACACCGGTGCCTCAGCG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_Up_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACTGATCAAGGCGAATACTTCAGCCGAGCTGCTGCTGGAACTGCTGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_Up_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GCGGCGCGCGACGCGGCGCCGACGCGGTCATGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_Dn_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GCGTCGGCGCCGCGTCGCGCGCCGCAGCC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_Up_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GGGACCCGCGCGGTCGATCCCCGCACTTGATCAGGCCGGTGATGCCGGCC</monospace></td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Primers used for screening A</italic>. <italic>verrucosospora exconjugant gDNA for targeted in-frame deletions</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_KO_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>CCTTCAAGAGATCCCCGAGG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad10_KO_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>CGTCATCGGAACTCCCTGG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_KO_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>CTCCTTCTGTTTGGGTGACG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">mad31_KO_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GAGTGCTTCAGGTGAGAACG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_KO_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>GGTCTCAGCCCGTCGTTC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">tmn8_KO_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>TGTGCTGCTCGACCTGTC</monospace></td></tr><tr><td align="left" colspan="2" rowspan="1"><italic>Primers used for creating pIB139 genetic complementation constructs</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">pIB139_mad10_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>AGGATCCACATATGTTGGGGATCCTATGAGCGATTCGGTTG</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">pIB139_mad10_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>GATATCGCGCGCGGCCGCGGATCCTTCACGCCGCAGGTTCC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">pIB139_mad31_Fw</td><td align="left" rowspan="1" colspan="1"><monospace>CCACATATGTTGGGGATCCTATGGGCATGACCTCGC</monospace></td></tr><tr><td align="left" rowspan="1" colspan="1">pIB139_mad31_Rv</td><td align="left" rowspan="1" colspan="1"><monospace>CGCGCGCGGCCGCGGATCCTTCATCCGAAGGAAATGG</monospace></td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0239054.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.t002</object-id><label>Table 2</label><caption><title>Plasmids used in this study.</title></caption><alternatives><graphic id="pone.0239054.t002g" xlink:href="pone.0239054.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Name</th><th align="justify" rowspan="1" colspan="1">Description</th><th align="justify" rowspan="1" colspan="1">Source</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">pYH7</td><td align="justify" rowspan="1" colspan="1"><italic>tsr</italic>, <italic>bla</italic>, <italic>aac(3)IV</italic>, <italic>cos</italic>, <italic>oriT</italic>, PT7, PT3, <italic>oripIJ101</italic>, <italic>oriColEI</italic>. In frame deletion in <italic>Streptomyces</italic> by homologous recombination</td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]</td></tr><tr><td align="justify" rowspan="1" colspan="1">pIB139</td><td align="justify" rowspan="1" colspan="1">aac(3)IV, oriT, attP (&#x003a6;C31), int, PermE*, oripUC. Integrative plasmid for <italic>in trans</italic> complementation&#x000a0;</td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref010" ref-type="bibr">10</xref>]</td></tr><tr><td align="justify" rowspan="1" colspan="1">pYH7-<italic>tmn8</italic></td><td align="justify" rowspan="1" colspan="1">Gene deletion construct for <italic>tmn8&#x000a0;</italic></td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="justify" rowspan="1" colspan="1">pYH7-<italic>mad10</italic></td><td align="justify" rowspan="1" colspan="1">Gene deletion construct for <italic>mad10</italic></td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="justify" rowspan="1" colspan="1">pYH7-<italic>mad31</italic></td><td align="justify" rowspan="1" colspan="1">Gene deletion construct for <italic>mad31</italic></td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="justify" rowspan="1" colspan="1">pIB139-<italic>mad10</italic></td><td align="justify" rowspan="1" colspan="1">Construct for the heterologous expression of <italic>mad10</italic></td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="justify" rowspan="1" colspan="1">pIB139-<italic>mad31</italic></td><td align="justify" rowspan="1" colspan="1">Construct for the heterologous expression of <italic>mad31</italic></td><td align="justify" rowspan="1" colspan="1">This study</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0239054.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.t003</object-id><label>Table 3</label><caption><title>Bacteria strains used in this study.</title></caption><alternatives><graphic id="pone.0239054.t003g" xlink:href="pone.0239054.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Name</th><th align="justify" rowspan="1" colspan="1">Description</th><th align="justify" rowspan="1" colspan="1">Source</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>Actinomadura verrucosospora</italic> NRRL B-18236</td><td align="justify" rowspan="1" colspan="1">Tetromadurin (SF2487/A80533) (<bold>1</bold>) producer</td><td align="justify" rowspan="1" colspan="1">NRRL</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces longisporoflavus</italic> 83E6</td><td align="justify" rowspan="1" colspan="1">Tetronasin (<bold>2</bold>) producer</td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic> sp. NRRL 11266</td><td align="justify" rowspan="1" colspan="1">Tetronomycin (<bold>3</bold>) producer</td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Actinomadura verrucosospora</italic> &#x00394;mad10</td><td align="justify" rowspan="1" colspan="1"><italic>A</italic>. <italic>verrucosospora</italic> in which 906/1404 bp of the <italic>mad10</italic> coding frame has been deleted. No longer produces tetromadurin. Producer of T-17.</td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Actinomadura verrucosospora</italic> &#x00394;mad31</td><td align="justify" rowspan="1" colspan="1"><italic>A</italic>. <italic>verrucosospora</italic> in which 291/561 bp of the <italic>mad31</italic> coding frame has been deleted. No longer produces tetromadurin.</td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11</td><td align="justify" rowspan="1" colspan="1"><italic>S</italic>. <italic>longisporoflavus</italic> 83E6 in which 1356 nt of the <italic>tsn11</italic> coding frame has been deleted. Producer of <bold>17</bold></td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15</td><td align="justify" rowspan="1" colspan="1"><italic>S</italic>. <italic>longisporoflavus</italic> 83E6 in which the entire 621 bp <italic>tsn15</italic> coding frame has been deleted</td><td align="justify" rowspan="1" colspan="1">[<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15-<italic>mad31</italic></td><td align="justify" rowspan="1" colspan="1"><italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 containing the integrative pIB139-<italic>mad31</italic> plasmid.</td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15-<italic>tmn8</italic></td><td align="justify" rowspan="1" colspan="1"><italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 containing the integrative pIB139-<italic>tmn8</italic> plasmid.</td><td align="justify" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Streptomyces</italic>. sp NRRL 11266 &#x00394;tmn8</td><td align="justify" rowspan="1" colspan="1"><italic>S</italic>. sp NRRL 11266 in which the entire 573 bp <italic>tmn8</italic> coding frame has been deleted. No longer produces tetronomycin.</td><td align="justify" rowspan="1" colspan="1">This study</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec004"><title>Growth and maintenance of actinomycete cultures</title><p>All actinomycete mycelial liquid cultures were grown at 30&#x000b0;C at 200 rpm in conical flasks. The liquid medium was filled to no more than 1/5 of the total flask volume. A steel spring was placed at the bottom of each flask that extended around the inside face, preventing the culture from clumping. Foam bungs were used to seal the flask. <italic>Actinomadura verrucosospora</italic> was maintained on oatmeal agar (20 g/L oatmeal, 20 g/L agar) while <italic>S</italic>. <italic>longisporoflavus</italic> was maintained on TWM medium (5 g/L <sc>d</sc>-glucose, 10 g/L sucrose, 5 g/L tryptone, 2.5 g/L yeast extract, 0.036 g/L EDTA, 15 g/L agar, pH 7.1.). <italic>S</italic>. sp NRRL 11266 was maintained on SFM medium (20 g/L soy flour, 20 g/L <sc>d</sc>-mannitol, 20 g/L agar).</p></sec><sec id="sec005"><title>Genomic DNA extraction</title><p>For the preparation of genomic DNA (gDNA), 250&#x02013;500 &#x003bc;L of mycelia was centrifuged in a 1.5 mL microcentrifuge tube to pellet the cells and the supernatant was discarded. The cell pellet was resuspended in 500 &#x003bc;L of SET buffer (20 mM TrisCl, 75 mM NaCl, 75 mM EDTA, pH 7.2) containing 10 &#x003bc;L of lysozyme solution (50 mg/mL). After incubation at 37&#x000b0;C for 1 h, 60 &#x003bc;L of 10% SDS (w/v) and 10 &#x003bc;L of proteinase K (20 mg/mL) were added and the tube was incubated at 55&#x000b0;C for an additional 2 h. The sample was then mixed with 300 &#x003bc;L of 5 M NaCl and 500 &#x003bc;L of chloroform and centrifuged at 2200 x <italic>g</italic> for 15 min. The aqueous upper layer was transferred to a fresh microcentrifuge tube using a T1000 pipette tip with the end cut off to avoid shearing the gDNA. To precipitate the gDNA, 0.6x volumes of isopropanol was added followed by gentle mixing. The precipitated gDNA was washed twice in 70% ethanol before being air dried for 5&#x02013;10 min. The gDNA pellet was dissolved in 100&#x02013;200 &#x003bc;L of distilled water.</p></sec><sec id="sec006"><title>Genome sequencing</title><p>Nextera shotgun and Nextera mate-pair libraries were constructed from high molecular weight genomic DNA isolated from <italic>Actinomadura verrucosospora</italic> NRRL-B18236. Sequencing was carried out on an Illumina MiSeq platform using the Illumina V2 500 cycles kit in 2 &#x000d7; 250 bp mode. Reads were processed using a custom adapter trimming tool(fastq_miseq_trimmer). Read pairs were then preassembled using FLASH v1.2.11 (<ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/FLASH">https://ccb.jhu.edu/software/FLASH</ext-link>). For <italic>de novo</italic> assembly we used newbler v3.0. Several assemblies were carried out using either all or subsets of the input dataset, and the best assembly was selected using a score calculated from scaffold N50, edge and total number of contigs. The best assembly was polished using Pilon. ORFs were predicted <italic>ab initio</italic> using a customised version of the FGENESB pipeline V2.0 (2008) [<ext-link ext-link-type="uri" xlink:href="http://www.softberry.com/">www.softberry.com</ext-link>] and BLAST-searched against a filtered NCBI NR and KEGG datasets. Customised linguistic analysis was used for transfer of gene annotations. Annotation results were saved in EMBL format and manually curated in Artemis (<ext-link ext-link-type="uri" xlink:href="http://www.sanger.ac.uk/science/tools/artemis">http://www.sanger.ac.uk/science/tools/artemis</ext-link>). The revised genome sequence has been deposited in GenBank under accession number CP053892. The tetromadurin biosynthesis gene cluster (<italic>mad</italic> gene cluster) can be found within the genome using the accession CP053892:2037887&#x02013;2164555.</p></sec><sec id="sec007"><title>Revised sequence of Mad10</title><p>Close examination of the <italic>mad10</italic> gene revealed an alternative ATG start codon 15 codons upstream (corresponding to the amino acids MSDSVVIIGAGPVGL) to the start codon presented in Genbank: QKG20158. This alternative start codon was preferred as including these 15 extra amino acids improved its alignment with homologues proteins (see <bold><xref ref-type="supplementary-material" rid="pone.0239054.s012">S12 Fig</xref></bold> in the supplementary material for details), suggesting it is the true start codon.</p><p>For clarity, the revised sequence of Mad10 used for alignments and expressed from pIB139-<italic>mad10</italic> is presented below (bolded residues highlight the additional amino acid residues):</p><p><monospace><bold>MSDSVVIIGAGPVGL</bold>MLAHELALAGVRTVVIERRPEIDARTVSGLIHERSVELLEQRGLMEQIRREDGEPLVWDRLHFASFWLDMSELAKTDHSVVLLQTRIQRLLSDRAAARGVHILRRHELVGLSQDEDGVTARVHSPLGEEEIRCGYLVGCDGEDSAVRELAGFAVTRSGPSWYGLLADVGSYAGPVGAGSFHEGGMFGQFGDASTMFRLMTIEIGVEAPPAEQPVTLEEVRASIERITGERPTVEEPLWLHRHGNVTILADEYRNGRVFLAGDAAHFQFHPAGHAVTIGLQDAVNLGWKLAAKLQGWAPAGLLDSYDAERRPYGRRACVYGRAQMALLDTADGPSALREVFGELLDHDVVNRHLVRAATDARYPMGQAEDLVGRRVPLVSLSTPGGEVPVAETLHAARGVLLDLSGGTEPPDVTGWKDRVDVVAAEPTPEIPASAVLVRPDGHIAWAGEAVGEGLHTALAAWFGEPAA</monospace></p></sec><sec id="sec008"><title>Creation of pYH7 and pIB139 constructs</title><p>The general method used to create a gene-deletion construct was to PCR amplify 2 kb regions upstream and downstream of the gene of interest. The DNA polymerase used was Phusion<sup>TM</sup> High Fidelity Master Mix with GC Buffer (New England Biolabs). The PCR primers used to amplify each 2 kb fragment contained regions of overlap with both <italic>Nde</italic>I-linearised pYH7 [<xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>] and the other 2 kb fragment, enabling all three to be seamlessly joined using Hot Fusion DNA assembly [<xref rid="pone.0239054.ref009" ref-type="bibr">9</xref>]. The assembled DNA product was then transformed into chemically competent <italic>E coli</italic> NovaBlue cells. Colony PCR was used to identify <italic>E</italic>. <italic>coli</italic> clones containing the correctly assembled insert, which were then fully sequenced using Sanger sequencing. The same protocol was followed to create the pIB139 [<xref rid="pone.0239054.ref010" ref-type="bibr">10</xref>] constructs, except the vector was linearised using <italic>Xba</italic>I and only a single fragment was inserted.</p></sec><sec id="sec009"><title>Intergeneric conjugation of <italic>Actinomadura verrucosospora</italic>, <italic>Streptomyces longisporoflavus</italic>, and <italic>Streptomyces</italic> sp. NRRL 11266</title><p>The DNA methylation deficient ET12567/pUZ8002 cells transformed with the pYH7 or pIB139 plasmid to be transferred into the actinomycete host were grown to an A<sub>600</sub> of 0.4&#x02013;0.6 in 2TY (16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) medium containing selective antibiotics. The ET12567/pUZ8002 cells were then spun down and washed twice in 20 mL of 2TY medium before being resuspended in 300 &#x003bc;L of 2TY. The actinomycete strain to be conjugated (either as mycelia or spores) was prepared following the protocol from <italic>Practical Streptomyces Genetics</italic> [<xref rid="pone.0239054.ref011" ref-type="bibr">11</xref>]. After gentle mixing, the two bacteria types were plated onto 35 mL of SFM containing 10&#x02013;20 mM MgCl<sub>2</sub> and left at 30&#x000b0;C for 12&#x02013;20 h. The surface of the plate was then flooded with 1 mL of MQ water containing 35 &#x003bc;L of apramycin (50 mg/mL) and 25 &#x003bc;L nalidixic acid (25 mg/mL). The plate was then incubated at 30&#x000b0;C to promote the growth of exconjugants. Exconjugants were verified by restreaking onto SFM containing 30&#x02013;50 &#x003bc;g/mL apramycin and 25 &#x003bc;g/mL nalidixic acid.</p></sec><sec id="sec010"><title>Metabolite analysis</title><p>To detect the production of tetromadurin, <italic>A</italic>. <italic>verrucosospora</italic> was grown at 30&#x000b0;C for seven days on oatmeal agar. To detect the production of tetronasin, <italic>S</italic>. <italic>longisporoflavus</italic> was grown at 30&#x000b0;C on tsn medium B (30 g/L tryptic soy broth, 3 g/L CaCO<sub>4</sub>, 100 g/L dextrin, 20 g/L agar, trace elements: 4 mg/L FeSO<sub>4</sub>, 4 mg/L ZnSO<sub>4</sub>, 0.6 mg/L CuSO<sub>4,</sub> 0.4 mg/L MnSO<sub>4</sub>, 0.4 mg/L KMoO<sub>4</sub>). To detect the production of tetronomycin, <italic>S</italic>. sp NRRL 11266 was grown at 30&#x000b0;C on SFM medium. Following the fermentation, the agar was cut into cubes and extracted by submerging in ethyl acetate. The ethyl acetate was then evaporated to dryness under reduced pressure and the organic extract was redissolved 1 mL of methanol and centrifuged at 20,000 g for 20 min to remove any particulates, followed by HPLC-MS analysis. For the analysis of small molecules, an HPLC (Hewlett Packard, Agilent Technologies 1200 series) coupled to a mass spectrometer (Thermo Finnigan MAT LTQ) was used. The HPLC-MS was fitted with a 250 mm x 4.6 mm 5&#x003bc;m C18 reverse-phase column (5&#x003bc; OSD3, 100 &#x000c5;. Phenomenex, USA). The mobile phase consisted of 20 mM ammonium acetate and methanol. The mobile phase flow rate was 0.7 mL/min with the following gradient: 0&#x02013;5 min, 5&#x02013;75% methanol; 5&#x02013;30 min, 75&#x02013;95% methanol, 30&#x02013;34 min, 95% methanol 35&#x02013;36 min, 95&#x02013;5% methanol. The mass spectrometer was operated in positive electrospray ionisation mode set to full scan (from m/z 200&#x02013;2000).</p></sec><sec id="sec011"><title>Construction of phylogenetic trees and protein sequence alignments</title><p>Maximum-likelihood (based on the Le-Cascuel model [<xref rid="pone.0239054.ref012" ref-type="bibr">12</xref>]) phylogenetic trees were created using MEGA7 [<xref rid="pone.0239054.ref013" ref-type="bibr">13</xref>] by following the protocol described in [<xref rid="pone.0239054.ref014" ref-type="bibr">14</xref>]. 1000 bootstrap replicates were performed. Positions with less than 95% site-coverage were excluded. Protein sequence alignments were performed using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>].</p></sec></sec><sec sec-type="results" id="sec012"><title>Results</title><sec id="sec013"><title>Identification of the mad gene cluster in <italic>A</italic>. <italic>verrucosospora</italic></title><p>A strain of the <italic>A</italic>. <italic>verrucosospora</italic> NRRL B-18236 was obtained from the Agricultural Research Service Culture Collection (NRRL). Prior to sequencing, the competence of this strain as a tetromadurin producer was tested. <italic>A</italic>. <italic>verrucosospora</italic> NRRL B-18236 was fermented for seven days on oatmeal agar followed by LC-MS analysis of the organic extract, where tetromadurin ([M+Na<sup>+</sup>] = 783.8, &#x003bb;<sub>MAX</sub> = 252 nm, 300 nm (MeOH)) was clearly detectable (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s002">S2 Fig</xref></bold>).</p><p>Whole-genome sequencing was then performed using a combined shotgun and long-range mate pair MiSeq approach. The genome was assembled into a single 10.215 Mbp scaffold (Genbank: CP053892) and analysed by AntiSMASH 4.0 [<xref rid="pone.0239054.ref016" ref-type="bibr">16</xref>] to identify biosynthetic gene clusters. Only one of the detected biosynthetic gene clusters, ca. 110 kbp and featuring 32 genes (CP053892:2037887&#x02013;2164555), possessed the biosynthetic features likely required for tetromadurin biosynthesis. The exact boundaries of the tetromadurin biosynthetic gene cluster (the <italic>mad</italic> gene cluster) were decided on the basis of flanking genes whose annotation suggested no obvious connection with tetromadurin biosynthesis (such as primary metabolism). The proposed functions of the genes in the <italic>mad</italic> gene cluster, predicted using BLAST [<xref rid="pone.0239054.ref017" ref-type="bibr">17</xref>], is presented in <bold><xref ref-type="fig" rid="pone.0239054.g002">Fig 2</xref></bold>. A diagram of the spatial organisation of the <italic>mad</italic> gene cluster is presented in <bold><xref ref-type="fig" rid="pone.0239054.g003">Fig 3</xref></bold>. The majority of genes within the <italic>mad</italic> gene cluster could be ascribed plausible roles in tetromadurin biosynthesis, enabling us to propose a complete biosynthetic pathway (<bold>Figs <xref ref-type="fig" rid="pone.0239054.g004">4</xref></bold> and <bold><xref ref-type="fig" rid="pone.0239054.g005">5</xref></bold>). The rationale for this biosynthetic pathway is discussed in the following sections.</p><fig id="pone.0239054.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g002</object-id><label>Fig 2</label><caption><title>Predicted functions of genes in the <italic>mad</italic> gene cluster.</title><p>ATa = malonyl-CoA selective AT domain (acetate unit). ATp = (<italic>2S</italic>)-methylmalonyl-CoA selective AT domain (propionate unit). ATm = predicted (<italic>2R</italic>)-methoxymalonyl-ACP selective AT domain.</p></caption><graphic xlink:href="pone.0239054.g002"/></fig><fig id="pone.0239054.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g003</object-id><label>Fig 3</label><caption><title>The tetromadurin biosynthetic gene cluster (the <italic>mad</italic> gene cluster).</title><p>The total size of the <italic>mad</italic> gene cluster is 110 kbp. A total of 32 were predicted to comprise the <italic>mad gene</italic> cluster. Genes are colour coded according to their predicted function.</p></caption><graphic xlink:href="pone.0239054.g003"/></fig><fig id="pone.0239054.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g004</object-id><label>Fig 4</label><caption><title>The proposed biosynthesis pathway of tetromadurin (part 1).</title><p>(I) The seven PKS enzymes (MadAI-MadAVIII) and predicted linear tetromadurin intermediates of the <italic>mad</italic> gene cluster. ATa domains contain the amino acid motifs associated with malonyl-CoA (acetate unit) incorporation. ATp domains contain the amino acid motifs associated with (2S)-methylmalonyl-CoA (propionate unit) incorporation. The ATm domain is predicted to recognise (<italic>2R</italic>)-methoxymalonyl-ACP. ER<sup>D</sup> domains are predicted to create a D-configured &#x003b1;-methyl group. B1 KRs are predicted to create D-configured &#x003b1;-methyl and &#x003b2;-hydroxyl groups. The KS domain in MadAI is a KS<sup>Q</sup> domain. The red crosses indicate domains that are predicted to be inactive on the basis of their amino acid sequence. (II) The key biosynthetic precursor 1,3-bisphosphoglycerate, involved in both tetronate formation and (<italic>2R</italic>)-methoxymalonyl-ACP biosynthesis. (III) Formation of glyceryl-ACP by the FkbH-like enzyme Mad14 and the ACP Mad12. (IV) Oxidation of glyceryl-ACP by the dehydrogenase Mad11 to form 2-hydroxy-3-oxopropionyl-ACP. (V) Oxidation of 2-hydroxy-3-oxopropionyl-ACP by the dehydrogenase Mad13 to form hydroxymalonyl-ACP. (VI) Methylation of hydroxymalonyl-ACP by the <italic>O</italic>-methyltransferase Mad15 to form (<italic>2R</italic>)-methoxymalonyl-ACP. (VII) The (<italic>2R</italic>)-methoxylmalonyl-ACP is incorporated by the MadAVI_AT_13. (VIII) Synthesis of a second pool of glyceryl-ACP by FkbH-like Mad7 and ACP Mad8. (IX) Glyceryl-ACP is a substrate of the FabH-like protein Mad16 that catalyses tetronate formation and concomitant chain release from the PKS. Bonds/atoms have been coloured red to highlight the chemical change.</p></caption><graphic xlink:href="pone.0239054.g004"/></fig><fig id="pone.0239054.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g005</object-id><label>Fig 5</label><caption><title>The proposed biosynthetic pathway of tetromadurin (part 2).</title><p>(X) In the first step of tetrahydrofuran formation, MadC catalyses epoxidation of the C24-C25 and C28-C29 <italic>E</italic> double bonds. (XI) The epoxide hydrolase MadB catalyses formation of the two tetrahydrofuran rings through a cascade epoxide ring-opening; (XII) Acetylation of the C41 hydroxyl group is catalysed by Mad17. (XIII) Elimination of the acetyl group by Mad18 forms the C40-C41 exocyclic double bond. (XIV) Hydroxylation of C36 by Mad29. It is possible this hydroxylation event takes place earlier in the biosynthesis (XV) Mad10 catalyses the formation of an oxadecalin containing intermediate <bold>10</bold>. (XVI) The equivalent oxadecalin intermediate in tetronasin biosynthesis acquired a water at C3 to form a hemiacetal [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Given the structural similarity between tetromadurin and tetronasin, it is likely the tetromadurin oxadecalin intermediate can be hydrated at C3 to form <bold>11</bold>. (XVII) Mad31 catalyses formation of the tetrahydropyran ring and dismantles the oxadecalin ring to form <bold>12</bold>. (XVIII) Mad30 then catalyses hydroxylation of C38, forming tetromadurin <bold>1</bold>. Bonds/atoms have been coloured red to highlight the chemical change.</p></caption><graphic xlink:href="pone.0239054.g005"/></fig></sec><sec id="sec014"><title>Polyketide synthase genes of the <italic>mad</italic> gene cluster</title><p>The <italic>mad</italic> gene cluster contains seven genes encoding type I polyketide synthase multienzymes (<italic>madAI</italic>-<italic>madAVII</italic>), collectively consisting of one loading and 14 extension modules. No thioesterase (TE) domain is present in any of the modules, as expected for a polyketide tetronate pathway [<xref rid="pone.0239054.ref018" ref-type="bibr">18</xref>]. The loading PKS module (MadAI_KS_LM) could be differentiated from the extension modules by its KS domain catalytic cysteine being replaced by a glutamine (KS<sup>Q</sup> domain) (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s003">S3 Fig</xref></bold>) [<xref rid="pone.0239054.ref019" ref-type="bibr">19</xref>]. The order in which the remaining PKS enzymes process the tetromadurin intermediate was then predicted based on the agreement of the proposed product with the actual structure of tetromadurin. The linear polyketide predicted by ordering the PKS enzymes MadAI-MadAVII (<bold>13</bold>) (i.e, MadAI initiates tetromadurin biosynthesis and performs two extension cycles before transferring the nascent polyketide chain to downstream to MadAII etc&#x02026;) is in near perfect agreement to the linear polyketide we predicted from retrobiosyntheic analysis of tetromadurin itself (<bold>14</bold>) (<bold><xref ref-type="fig" rid="pone.0239054.g006">Fig 6</xref></bold>). The placement of the C5-C6, C10-C11, C12 and C13 double bonds in <bold>14</bold> was guided by the recently isolated partially cyclised tetronasin intermediate [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>].</p><fig id="pone.0239054.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g006</object-id><label>Fig 6</label><caption><title>Hypothetical ACP-bound linear tetromadurin backbone.</title><p><bold>13</bold>: the hypothetical linear tetromadurin intermediate predicted to be produced by the MadAI-MadAVII arrangement. <bold>14</bold>: the hypothetical linear tetromadurin intermediate predicted from the structure of tetromadurin itself.</p></caption><graphic xlink:href="pone.0239054.g006"/></fig><p>The substrate selectivity of the acyltransferase (AT) domains were predicted from the presence of specific amino acid motifs, particularly the presence of a (H/T/V/Y)AFH (acetate-incorporating), or (Y/V/W)ASH (propionate-incorporating) motif (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s004">S4 Fig</xref></bold>) [<xref rid="pone.0239054.ref020" ref-type="bibr">20</xref>&#x02013;<xref rid="pone.0239054.ref022" ref-type="bibr">22</xref>]. The AT domain of the loading module contains the hybrid HASH motif, previously found in modules with a relaxed selectivity that can incorporate both malonyl-CoA and (2<italic>S</italic>)-methylmalonyl-CoA [<xref rid="pone.0239054.ref023" ref-type="bibr">23</xref>]. However, no congener of tetromadurin with one fewer methyl group has been reported, indicating that (2<italic>S</italic>)-methylmalonyl-CoA is still specifically recruited by the loading module. The AT domain of module 13 (MadAVI_AT_13) contains a YASH motif, indicating selectivity for a (2<italic>S</italic>)-methylmalonyl-CoA. However, based on the structure of tetromadurin this module should actually incorporate (2<italic>R</italic>)-methoxymalonyl-ACP to form the C4 methoxy group. The selectivity motifs of AT domains that incorporate (2<italic>R</italic>)-methoxymalonyl-ACP are poorly defined and typically resemble either a malonyl-CoA or (2<italic>S</italic>)-methylmalonyl-CoA selective domain [<xref rid="pone.0239054.ref024" ref-type="bibr">24</xref>]. However, given the <italic>mad</italic> gene cluster contains the genes to synthesise (2<italic>R</italic>)-methoxymalonyl-ACP (discussed below), it is likely that MadAVI_AT_13 really is selective for this uncommon extension unit.</p><p>With one exception, the tally of reducing domains present in each module is also consistent with the structure of tetromadurin. Modules 2, 4, 8, and 11 all contain a ketoreductase (KR), dehydratase (DH), and enoylreductase (ER) domain, consistent with complete saturation at C27, C23, C15, and C9, respectively (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s005">S5 Fig</xref></bold>). Since modules 4 and 11 incorporate propionate units, the ER domains in these modules also determine the configuration of the C33 and C37 &#x003b1;-methyl groups, respectively. These ER domains both contain amino acid motifs associated with the <sc>d</sc>-configuration (lacking the key tyrosine residue) [<xref rid="pone.0239054.ref025" ref-type="bibr">25</xref>], consistent with the <sc>d</sc>-configured &#x003b1;-methyl substituents at these positions (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s005">S5 Fig</xref></bold>).</p><p>The DH domains of modules 1, 3, 6, 9, 10, and 13 are all appropriately placed to form the &#x0237a;-&#x003b2; double bonds at C29, C25, C19, C13, C11, and C5, respectively. Although module 5 contains a DH domain, C21 contains a hydroxyl group in the final tetromadurin structure, suggesting that MadAIII_DH_5 is inactive. Closer examination of MadAIII_DH_5 confirmed this inactivity, as it is missing the tyrosine from the YGP motif. The tyrosine side chain of the YGP motif in DH domains is proposed to assist binding to the &#x003b2;-hydroxyl group of the substrate [<xref rid="pone.0239054.ref019" ref-type="bibr">19</xref>] and has been shown experimentally to be essential [<xref rid="pone.0239054.ref026" ref-type="bibr">26</xref>]. The remaining DH domains all appear to be active (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s006">S6 Fig</xref></bold>).</p><p>KR domains exert significant stereochemical influence over growing polyketide chains, determining the stereochemistry of the &#x003b2;-hydroxyl group and (where appropriate) the &#x003b1;-group of each extension unit. In the proposed MadAI-MadAVII module order, the KR domains of module 5, 7, and 12 are appropriately placed to form the hydroxyl groups at C21, C17, and C7, respectively. In the case of tetromadurin, all backbone &#x003b2;-hydroxyl groups and the &#x003b1;-methyl groups adjacent to these hydroxyls (C35 and C38) are in the <sc>d</sc>-configuration, indicating the activity of B1 type KR domains [<xref rid="pone.0239054.ref019" ref-type="bibr">19</xref>]. The distinguishing features of a B1 KR domain are an (L,V,I)DD motif and the absence of a proline (a feature of B2-type KRs) two residues C-terminal of the catalytic tyrosine [<xref rid="pone.0239054.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0239054.ref028" ref-type="bibr">28</xref>]. Protein sequence analysis confirmed that the KR domains from modules 5 and 7 are indeed B1, but modules 12 and 14 and appear to be inactive (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s007">S7 Fig</xref></bold>). The module 12 and 14 KR domains both lack the key catalytic tyrosine residue, with module 12 also containing a deletion in its NADPH binding site [<xref rid="pone.0239054.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0239054.ref029" ref-type="bibr">29</xref>]. While the inactivity of KR_14 is consistent with the C3 keto group of tetromadurin, the inactivity of KR_12 is not. An inactive KR domain at this position should result in a keto group at C7 rather than the C7 <sc>d</sc>-hydroxyl group observed in the tetromadurin (<bold><xref ref-type="fig" rid="pone.0239054.g006">Fig 6</xref></bold>). Module 12 also contains a seemingly active DH domain that should reduce a C7 <sc>d</sc>-hydroxyl by a C6-C7 <italic>trans</italic> double bond. How the tetromadurin C7 hydroxyl group is formed is therefore unclear.</p></sec><sec id="sec015"><title>Genes for tetronate biosynthesis</title><p>The <italic>mad</italic> gene cluster contains homologues of all five glycerate-utilisation operon [<xref rid="pone.0239054.ref018" ref-type="bibr">18</xref>] genes: <italic>mad7</italic>, <italic>mad8</italic>, <italic>mad16</italic>, <italic>mad17</italic>, and <italic>mad18</italic>. <italic>mad7</italic> and <italic>mad8</italic> respectively encode a FkbH-like protein and a standalone acyl carrier protein (ACP) found in the biosynthetic pathways of other tetronates [<xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0239054.ref030" ref-type="bibr">30</xref>]. Mad7 likely catalyses formation of glyceryl-ACP from 1,3-bisphosphoglycerate using Mad8 as the ACP scaffold. Mad16 is the FabH-like protein known for catalysing tetronate formation and chain release [<xref rid="pone.0239054.ref018" ref-type="bibr">18</xref>]. Finally, Mad17 and Mad18 are homologues of the acyltransferase Agg4 and the dehydratase Agg5, respectively, responsible for exocyclic double bond formation in agglomerin biosynthesis [<xref rid="pone.0239054.ref031" ref-type="bibr">31</xref>]. Mad17 likely catalyses the acetylation of the C41 hydroxyl, followed by Mad17 catalysing elimination of the acyl group to form the exocyclic C40-C41 double bond (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s008">S8 Fig</xref></bold>).</p></sec><sec id="sec016"><title>Genes for (2<italic>R</italic>)-methoxymalonyl-ACP biosynthesis</title><p>Several polyketide natural products are known to incorporate the unusual methoxymalonate extender unit derived from (2<italic>R</italic>)-methoxymalonyl-ACP [<xref rid="pone.0239054.ref032" ref-type="bibr">32</xref>], the first example being the macrocyclic immunosuppressant FK520 [<xref rid="pone.0239054.ref024" ref-type="bibr">24</xref>]. Five genes in the FK520 BGC were identified as responsible for the biosynthesis of (2<italic>R</italic>)-methoxymalonyl-ACP from 1,3-bisphosphoglycerate [<xref rid="pone.0239054.ref024" ref-type="bibr">24</xref>]. Homologues of these five genes have since been found in the BGCs of other natural products known to incorporate (2<italic>R</italic>)-methoxymalonyl-ACP, such as tautomycin [<xref rid="pone.0239054.ref033" ref-type="bibr">33</xref>], oxazolomycin [<xref rid="pone.0239054.ref034" ref-type="bibr">34</xref>], and geldanamycin [<xref rid="pone.0239054.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0239054.ref036" ref-type="bibr">36</xref>]. The <italic>mad</italic> gene cluster also contains homologues of these genes: <italic>mad11</italic>, <italic>mad12</italic>, <italic>mad13</italic>, <italic>mad14</italic>, and <italic>mad15</italic>, which appear to be part of a single operon. The gene <italic>mad14</italic> encodes a second FkbH-like protein, distinct from Mad8, that appears to catalyse formation of a second pool of glyceryl-ACP using 1,3 bisphosphoglycerate and Mad12, another standalone ACP. Whether the two pools of glyceryl-ACP can interchangeably be used in tetronate formation or (2<italic>R</italic>)-methoxymalonyl-ACP biosynthesis is unknown. The primary hydroxyl group of glyceryl-ACP undergoes two oxidation events to form (2<italic>R</italic>)-hydroxymalonyl-ACP. Based on its similarity to the dehydrogenase enzymes in the FK520 pathway, Mad11 is proposed to catalyse the first oxidation, forming 2-hydroxy-3-oxopropionyl-ACP. Mad13 then catalyses the second oxidation to form (2<italic>R</italic>)-hydroxymalonyl-ACP. The <italic>O</italic>-methyltransferase Mad15 likely converts (2<italic>R</italic>)-hydroxymalonyl-ACP into (2<italic>R</italic>)-methoxymalonyl-ACP (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s009">S9 Fig</xref></bold>). The exact timing of <italic>O</italic>-methylation is uncertain, with some evidence suggesting it precedes the oxidation steps [<xref rid="pone.0239054.ref037" ref-type="bibr">37</xref>].</p></sec><sec id="sec017"><title>Tetrahydrofuran ring formation</title><p>The <italic>mad</italic> gene cluster encodes an epoxidase (MadC) and an epoxide hydrolase (MadB), homologues of which are present in the BGCs of many other tetrahydrofuran-containing polyethers [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0239054.ref037" ref-type="bibr">37</xref>&#x02013;<xref rid="pone.0239054.ref039" ref-type="bibr">39</xref>]. In a mechanism first proposed for monensin [<xref rid="pone.0239054.ref040" ref-type="bibr">40</xref>], the epoxidase and epoxide hydrolase catalyse a regio- and stereospecific oxidation cyclisation to form one or multiple rings. It is likely that MadC catalyses the stereospecific epoxidation of the C24-C25 and C28-C29 <italic>E</italic> double bonds. MadB then catalyses opening of the two epoxide rings to form two tetrahydrofuran rings (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s010">S10 Fig</xref></bold>). The timing of tetrahydrofuran formation in polyether is not certain, though evidence from other polyether pathways suggests it may occur whilst the intermediate is still bound to the PKS [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0239054.ref041" ref-type="bibr">41</xref>].</p></sec><sec id="sec018"><title>Cyclohexane and tetrahydrofuran ring formation</title><p>The gene <italic>mad10</italic> is homologous to <italic>tsn11</italic> and <italic>tmn9</italic> from the <italic>tsn</italic> and <italic>tmn</italic> gene clusters, respectively. All three genes encode homologues of PyrE3, the [4+2] cyclase (Diels-Alderase) responsible for catalysing dialkyldecalin formation in the biosynthesis of pyrroindomycin A [<xref rid="pone.0239054.ref042" ref-type="bibr">42</xref>]. The discovery that PyrE3 catalyses an apparent [4+2] cycloaddition was surprising given its homology to MtmOIV-family FAD-dependent monooxygenase. Tsn11, despite also resembling an FAD-dependent monooxygenase, was recently demonstrated to catalyse an apparent inverse-electron demand hetero-Diels-Alder reaction to convert a tetronasin precursor <bold>17</bold> (in which the cyclohexane and tetrahydropyran rings have not yet formed) (<bold><xref ref-type="fig" rid="pone.0239054.g009">Fig 9C</xref></bold>) into an oxadecalin-containing intermediate [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. We therefore propose that Mad10 catalyses an equivalent reaction in tetromadurin biosynthesis (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s011">S11 Fig</xref></bold>). In support of this, Mad10, like Tsn11, also contains mutations in several of four conserved arginine residues involved in NADPH utilisation, indicating it is not a functional monooxygenase (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s012">S12 Fig</xref></bold>) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0239054.ref044" ref-type="bibr">44</xref>]. Further, inspection of a maximum-likelihood phylogenetic tree revealed that while Tmn9, Mad10, and Tsn11 form a clade together, they are more related to the PyrE3-like [4+2] cyclases [<xref rid="pone.0239054.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0239054.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0239054.ref045" ref-type="bibr">45</xref>&#x02013;<xref rid="pone.0239054.ref048" ref-type="bibr">48</xref>] than to their homologues that are <italic>bona fide</italic> FAD-dependent monooxygenases [<xref rid="pone.0239054.ref043" ref-type="bibr">43</xref>, <xref rid="pone.0239054.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0239054.ref051" ref-type="bibr">51</xref>] (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s013">S13 Fig</xref></bold>).</p><p><italic>mad31</italic> is a homologue of <italic>tsn15</italic> and <italic>tmn8</italic>, and all are homologs of <italic>vstJ</italic>, which encodes an enzyme responsible for catalysing spirotetronate formation via an intramolecular [4+2] cycloaddition in versipelostatin biosynthesis [<xref rid="pone.0239054.ref046" ref-type="bibr">46</xref>]. Tsn15 was recently demonstrated to catalyse the final step in tetronasin biosynthesis, dismantling the oxadecalin intermediate produced by Tsn11 and forming the tetrahydropyran ring [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. The crystal structure of Tsn15 has been solved and a tryptophan residue essential for substrate binding identified [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Mad31 contains a tryptophan at the equivalent locus, suggesting that tetromadurin biosynthesis also proceeds via an oxadecalin intermediate [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>] (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s014">S14 Fig</xref></bold>).</p></sec><sec id="sec019"><title>Hydroxylation of C36 and C38</title><p>Two cytochrome P450 enzymes are encoded in the <italic>mad</italic> gene cluster. One of these, Mad29, is homologous to Tsn12 (51% identity) and Tmn14 (32% identity)&#x02014;the cytochrome P450s encoded by the <italic>tsn</italic> and <italic>tmn</italic> gene clusters, respectively [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]. Tmn14 is predicted to catalyse the hydroxylation of C28 in tetronomycin while Tsn12 is predicted to catalyse the hydroxylation of the equivalent carbon (C30) in tetronasin biosynthesis (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s015">S15 Fig</xref></bold>) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]. By analogy, Mad29 is therefore proposed to catalyse hydroxylation of C36 in tetromadurin, leaving the second cytochrome P450, Mad30, to catalyse hydroxylation of C38 (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s015">S15 Fig</xref></bold>). No ferredoxin gene is present in the <italic>mad</italic> gene cluster, so presumably one encoded elsewhere in the genome is used to regenerate the cytochrome cofactor.</p></sec><sec id="sec020"><title>Other genes in the <italic>mad</italic> gene cluster</title><p>Finally, the <italic>mad</italic> gene cluster contains several other genes likely involved in transcriptional regulation or export of tetromadurin itself. On one end of the <italic>mad</italic> gene cluster the genes <italic>mad1</italic> and <italic>mad2</italic> encode predicted SARP [<xref rid="pone.0239054.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0239054.ref053" ref-type="bibr">53</xref>] and LuxR [<xref rid="pone.0239054.ref054" ref-type="bibr">54</xref>] transcriptional regulators, respectively. Another gene, <italic>mad27</italic>, encodes a putative MarR (multiple antibiotic resistance regulator)-like transcriptional regulator. First described in <italic>E</italic>. <italic>coli</italic>, MarR is a transcriptional regulator of several genes that confer antibiotic resistance [<xref rid="pone.0239054.ref055" ref-type="bibr">55</xref>]. Adjacent to <italic>mad27</italic> are the genes <italic>mad25</italic> and <italic>mad26</italic> that encode an ABC transporter and an ABC transporter ATP-binding protein, respectively, both of which are likely involved in exporting tetromadurin from the cytoplasm [<xref rid="pone.0239054.ref056" ref-type="bibr">56</xref>]. Mad27 may induce expression of <italic>mad25</italic> and <italic>mad26</italic> in the presence of tetromadurin, resulting in self-resistance [<xref rid="pone.0239054.ref057" ref-type="bibr">57</xref>, <xref rid="pone.0239054.ref058" ref-type="bibr">58</xref>].</p><p>The gene <italic>mad3</italic> encodes a 4'-phosphopantetheinyl transferase, required for activating ACP domains by attaching a 4'-phosphopantetheine prosthetic group. Adjacent to <italic>mad3</italic> is the phosphoesterase <italic>mad4</italic>, homologues of which are found in BGCs of other polyketides [<xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0239054.ref059" ref-type="bibr">59</xref>], the products of which may hydrolyse ACP-bound 4'-phosphopantetheine groups [<xref rid="pone.0239054.ref059" ref-type="bibr">59</xref>&#x02013;<xref rid="pone.0239054.ref061" ref-type="bibr">61</xref>]. <italic>mad6</italic> is predicted to encode type II thioesterase, likely having an &#x0201c;editing&#x0201d; role in hydrolysing PKS active sites containing mis-acylated intermediates [<xref rid="pone.0239054.ref062" ref-type="bibr">62</xref>, <xref rid="pone.0239054.ref063" ref-type="bibr">63</xref>]. The only gene that could not be assigned a plausible function is <italic>mad20</italic>, which encodes a hypothetical protein with no characterised homologues.</p></sec><sec id="sec021"><title>Creation of in-frame deletion mutants in <italic>mad10</italic> and <italic>mad31</italic></title><p>To verify experimentally that the <italic>mad</italic> gene cluster is indeed responsible for tetromadurin production (as the bioinformatics-based analysis strongly suggested), we performed in-frame deletions in the putative cyclase genes <italic>mad10</italic> and <italic>mad31</italic>. Each gene was individually knocked out in <italic>A</italic>. <italic>verrucosospora</italic> using a homologous recombination method, creating <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31 respectively (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s016">S16 Fig</xref></bold>). Tetromadurin production was completely abolished in the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant, indicating that, like Tsn11 and its homologue encoded in the <italic>tmn</italic> gene cluster, Tmn9, Mad10 is an essential biosynthetic enzyme. To attempt to rescue tetromadurin production in <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10, <italic>mad10</italic> was introduced back into the strain <italic>in trans</italic> on the &#x00278;C31 integrative plasmid pIB139 [<xref rid="pone.0239054.ref010" ref-type="bibr">10</xref>], resulting in tetromadurin production at 28% of wild type levels (<bold><xref ref-type="fig" rid="pone.0239054.g007">Fig 7</xref></bold>). The abolition of tetromadurin production in the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 and its subsequent rescue provides clear functional validation that the <italic>mad</italic> gene cluster is responsible for tetromadurin biosynthesis.</p><fig id="pone.0239054.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g007</object-id><label>Fig 7</label><caption><title>HPLC-MS analysis of <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31.</title><p><bold>a,</bold> The structure and molecular weight of tetromadurin (<bold>1</bold>) produced by <italic>A</italic>. <italic>verrucosospora</italic>. <bold>b,</bold> Extracted m/z = 783.8 HPLC-MS spectra from <italic>A</italic>. <italic>verrucosospora</italic> wild type (WT), <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10, and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 pIB139-<italic>mad10</italic>. <bold>c,</bold> Extracted m/z = 783.8 HPLC-MS spectra from <italic>A</italic>. <italic>verrucosospora</italic> WT, <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31, and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31 pIB139-<italic>mad31</italic>. All data are representative of three independent experiments.</p></caption><graphic xlink:href="pone.0239054.g007"/></fig><p>Tetromadurin production in the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31 mutant was also significantly decreased, producing tetromadurin at just 3% of wild type levels (<bold><xref ref-type="fig" rid="pone.0239054.g007">Fig 7</xref></bold>), indicating that, like its homologue Tsn15, it is an essential biosynthetic enzyme [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. However, <italic>in trans</italic> complementation of <italic>mad31</italic> using pIB139 did not rescue tetromadurin production (<bold><xref ref-type="fig" rid="pone.0239054.g007">Fig 7</xref></bold>). The failed <italic>mad31</italic> complementation, paired with the <italic>mad10</italic> complementation only restoring tetromadurin production in <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 to 28% wild type levels, suggest expression issues of the streptomycete-optimised vector pIB139 within <italic>A</italic>. <italic>verrucosospora</italic>.</p><p>The finding that the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 no longer produces tetromadurin, as previously shown for the analogous <italic>S</italic>. sp NRRL &#x00394;tmn9 and <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 mutants [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>], confirms that the PyrE3-like [4+2] cyclase family is essential for the biosynthesis of all three polyether tetronates. Likewise, <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31 and the previously analysed <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>] mutant indicate that a conserved VstJ-like cyclase is also essential for polyether tetronate biosynthesis. In parallel, we also analysed the consequences of deleting <italic>tmn8</italic>, the <italic>mad31</italic>/<italic>tsn15</italic> homologue from the <italic>tmn</italic> gene cluster. <italic>S</italic>. sp NRRL 11266 &#x00394;tmn8 was created and analysed for tetronomycin production. Fermentation and analysis of the organic extract of this strain confirmed it no longer produces tetronomycin, confirming that VstJ-like cyclases are also essential for the biosynthesis of all three polyether tetronates (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s017">S17</xref></bold> and <bold><xref ref-type="supplementary-material" rid="pone.0239054.s018">S18</xref> Figs</bold>).</p><p>Although <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 no longer produced tetromadurin, analysis of the total ion current (TIC) and photodiode array (PDA) spectrum of this mutant revealed that it produced a new metabolite that we named T-17 (<bold><xref ref-type="fig" rid="pone.0239054.g008">Fig 8A and 8B</xref></bold>).</p><fig id="pone.0239054.g008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g008</object-id><label>Fig 8</label><caption><title>Novel tetromadurin analogue produced by <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10.</title><p><bold>a,</bold> Total ion current (TIC) spectra of the crude organic extracts from <italic>A</italic>. <italic>verrucosospora</italic> wild type (WT) and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10. The other peaks represent unrelated species. Tetromadurin (<bold>1</bold>) was produced by <italic>A</italic>. <italic>verrucosospora</italic> and eluted at 19.8 min. A novel tetromadurin-related metabolite (named T-17) was produced by <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10, eluting at 17.4 min. <bold>b,</bold> HPLC-PDA (photodiode array) spectra of the crude organic extracts from <italic>A</italic>. <italic>verrucosospora</italic> WT and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10. <bold>c,</bold> Positive ion mode mass spectrum of tetromadurin (<bold>1</bold>) and T-17: *[M+Na]<sup>+</sup>, **[M+NH4]<sup>+</sup>, ***[M+H<sup>+</sup>, ****[M+H&#x02212;H<sub>2</sub>O]<sup>+</sup>, *****[M+H&#x02212;2.H<sub>2</sub>O]<sup>+</sup>. For tetromadurin (<bold>1</bold>): m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+Na]<sup>+</sup> = 783.81; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+NH<sub>4</sub>]<sup>+</sup> = 778.82; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+H]<sup>+</sup> = 761.84; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+H&#x02212;H<sub>2</sub>O]<sup>+</sup> = 739.84. For T-17: m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+Na]<sup>+</sup> = 767.69; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+NH<sub>4</sub>]<sup>+</sup> = 762.58; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+H]<sup>+</sup> = 745.63; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+H&#x02212;H<sub>2</sub>O]<sup>+</sup> = 727.70; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+H&#x02212;H<sub>2</sub>O]<sup>+</sup> = 727.70; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>+H&#x02212;2.H<sub>2</sub>O]<sup>+</sup> = 709.79. <bold>d,</bold> UV absorption spectra of tetromadurin (<bold>1</bold>) (&#x003bb;<sub>max</sub> = 252 nm, 300 nm, MeOH) and T-17 (&#x003bb;<sub>max</sub> = 236 nm, 300 nm, MeOH). The &#x02666; indicates an unrelated compound that is also detectable in the WT strain.</p></caption><graphic xlink:href="pone.0239054.g008"/></fig><p>T-17 was produced by <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 at ca. 50% the level of tetromadurin production by wild type <italic>A</italic>. <italic>verrucosospora</italic>. The mass spectra of T-17 contains peaks for putative [M+H]<sup>+</sup> (m/z = 745.6), [M+NH<sub>4</sub>]<sup>+</sup> (m/z = 762.6), and [M+Na]<sup>+</sup> (m/z = 767.7) ions, all of which are 16 Daltons less than the equivalent ions of tetromadurin (<bold><xref ref-type="fig" rid="pone.0239054.g008">Fig 8C and 8D</xref></bold>). A mass difference of 16 is diagnostic of an absent hydroxyl group, indicating that T-17 has the molecular formula C<sub>42</sub>H<sub>64</sub>O<sub>11</sub>. Likely candidates for this missing hydroxyl are either the C36 or the C38 primary hydroxyl group, predicted to be added by the cytochrome P450 enzymes Mad29 and Mad30, respectively. Closer examination of the mass/UV spectra of T-17 revealed striking similarities to the spectra of tetronasin intermediate <bold>17</bold> produced by <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11, in which the cyclohexane and tetrahydropyran rings are unformed [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Like <bold>17</bold>, the UV<sub>max</sub> of T-17 is also 236 nm (<bold><xref ref-type="fig" rid="pone.0239054.g008">Fig 8D</xref></bold>) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Furthermore, also as reported for <bold>17</bold>, the major ion of T-17 detected is the [M+H&#x02212;H<sub>2</sub>O]<sup>+</sup> adduct (m/z = 727.7) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. In contrast, the major ion detected for tetronasin and tetromadurin in organic extracts of their respective producer strains is the [M+Na]<sup>+</sup> adduct (<bold><xref ref-type="fig" rid="pone.0239054.g008">Fig 8</xref></bold>). These data indicate that in addition to lacking one of the primary hydroxyl groups added by a cytochrome P450, T-17 also contains a labile hydroxyl group that is readily lost in the mass spectrometer. The likely explanation for this observation is that T-17 is the tetromadurin equivalent of tetronasin intermediate <bold>17</bold>, containing a labile hydroxyl group due to the yet-unformed tetrahydropyran and cyclohexane rings (<bold><xref ref-type="fig" rid="pone.0239054.g009">Fig 9</xref></bold>). It appears that in the absence of the cyclohexane and tetrahydropyran rings, one of the cytochrome P450-catalysed hydroxylations, either at C36 (<bold>15</bold>) or C38 (<bold>16</bold>), is unable to occur (<bold><xref ref-type="fig" rid="pone.0239054.g009">Fig 9A and 9B</xref></bold>).</p><fig id="pone.0239054.g009" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0239054.g009</object-id><label>Fig 9</label><caption><title>Possible structures of T-17.</title><p><italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 no longer produces tetromadurin but produces a tetromadurin derivative, T-17. The mass spectrum of T-17 indicates that it is missing a primary hydroxyl group. The primary hydroxyl groups of tetromadurin are located at C36 and C38. Two possible structures of T-17 are therefore possible where either: <bold>a,</bold> the C38 hydroxyl group (<bold>15</bold>) or <bold>b,</bold> the C36 hydroxyl group (<bold>16</bold>) is absent. <bold>c,</bold> the structure of the tetronasin derivative <bold>17</bold> produced by <italic>Streptomyces longisporoflavus</italic> &#x00394;tsn11 [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>].</p></caption><graphic xlink:href="pone.0239054.g009"/></fig><p>In the tetronasin intermediate <bold>17,</bold> C30 bears a hydroxy group, indicating that cytochrome P450-catalysed hydroxylation of this carbon is not dependent on the cyclohexane and tetrahydropyran rings being present (<bold><xref ref-type="fig" rid="pone.0239054.g009">Fig 9C</xref></bold>). C36 is the equivalent position to C30 in <bold>17</bold>, offering a strong argument in favour of T-17 having the structure <bold>15.</bold> The second hydroxylation at C38 must occur after the cyclohexane ring has formed, suggesting it could be the final enzymatic step in tetromadurin biosynthesis (as has been depicted in <bold><xref ref-type="fig" rid="pone.0239054.g005">Fig 5</xref></bold>). Alternatively, the hydroxylation may precede tetrahydropyran formation.</p><p>Understanding the substrate tolerance of Mad10 and Mad31 could be important for using them as synthetic biology tools to create novel polyether tetronate antibiotics. In our previous study on tetronasin biosynthesis, we showed that Tmn9 and Tmn8 from the tetronomycin biosynthesis pathway could not substitute for Tsn11 and Tsn15, respectively [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]. Such a result is perhaps unsurprising, given that tetronasin and tetronomycin possess opposite configuration at their cyclohexane and tetrahydropyran rings. On the other hand, given that the stereochemistry of the cyclohexane and tetrahydropyran rings in tetromadurin is identical to tetronasin, we reasoned Mad10 and Mad31 would have a greater chance of successfully substituting for the equivalent <italic>tsn</italic> enzymes. To test this, <italic>mad10</italic> was expressed <italic>in trans</italic> in the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 mutant and <italic>mad31</italic> was expressed <italic>in trans</italic> in the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 mutant. However, HPLC analysis of these <italic>S</italic>. <italic>longisporoflavus</italic> mutants revealed that tetronasin production was not rescued in either case (<bold><xref ref-type="supplementary-material" rid="pone.0239054.s019">S19 Fig</xref></bold>), indicating that Mad10 and Mad31 are unable to accept the tetronasin intermediates.</p></sec></sec><sec sec-type="conclusions" id="sec022"><title>Discussion</title><p>In this work we have identified the biosynthetic gene cluster responsible for tetromadurin biosynthesis in <italic>Actinomadura verrucosospora</italic>. Our bioinformatics-based analysis of the <italic>mad</italic> gene cluster enabled almost of the genes to be assigned plausible roles in tetromadurin biosynthesis. Functional validation of the <italic>mad</italic> gene cluster was achieved by performing in-frame deletions in the putative cyclase genes <italic>mad10</italic> and <italic>mad31</italic>. The production of tetromadurin was abolished in both mutants, with the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant producing a new compound, T-17, that mass spectrometry data supports as being an intermediate lacking the cyclohexane and tetrahydropyran rings, and one cytochrome P450-catalysed hydroxylation. The production of T-17 by the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant provides experimental evidence that the enzymatic mechanism for cyclohexane and tetrahydropyran formation first described in tetronasin biosynthesis [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>] is conserved in tetromadurin biosynthesis. The missing primary hydroxyl group of T-17 also sheds light on the timing of events in the biosynthesis pathway, indicating that this second P450-catalysed hydroxylation can only occur following the Mad10 reaction. While comparison with tetronasin intermediate <bold>17,</bold> isolated from <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 provides convincing evidence that the structure of T-17 is <bold>15</bold>, we cannot rule out <bold>16</bold> being the true structure.</p><p>One feature of note in the polyketide synthase enzymes encoded in the <italic>mad</italic> gene cluster (MadAI-MadAVII) is the apparently inactive KR domain of module 12. This KR domain should reduce the C7 keto group to a <sc>d</sc>-hydroxyl group. One possible explanation could be that the KR domain of an adjacent module (either 11 or 13) performs this reduction. Domains acting externally to the PKS module they are located in have been proposed for other polyketide biosynthesis pathways [<xref rid="pone.0239054.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0239054.ref064" ref-type="bibr">64</xref>&#x02013;<xref rid="pone.0239054.ref066" ref-type="bibr">66</xref>]. The KR domain of either module 11 or 13 could therefore be responsible for forming the C7 hydroxyl, though additional work is required to confirm this.</p><p>In addition to studying tetromadurin biosynthesis, a <italic>S</italic>. sp NRRL 11266 &#x00394;tmn8 mutant was created. Following the deletions of <italic>mad10</italic> and <italic>mad31</italic> in <italic>Actinomadura verrucosospora</italic>, <italic>tmn8</italic> was the only [4+2] cyclase homologue gene from one of the known polyether tetronate biosynthesis pathways that had not been deleted [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0239054.ref008" ref-type="bibr">8</xref>]. The abolition of tetronomycin production in the <italic>S</italic>. sp NRRL 11266 &#x00394;tmn8 mutant confirms that both the VstJ-like and PyrE3-like cyclase homologues are essential for the biosynthesis of all three polyether tetronates, suggesting a conserved mechanism of cyclohexane and tetrahydropyran formation. Homologues of these two cyclase classes will likely be encoded in the biosynthetic gene clusters of any related polyether tetronates yet to be discovered.</p></sec><sec sec-type="supplementary-material" id="sec023"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0239054.s001"><label>S1 Fig</label><caption><title>Proposed biosynthetic precursors of the tetromadurin carbon backbone.</title><p>The carbon backbone of tetromadurin appears to be derived from six malonyl-CoA derived acetate units (red), eight (2<italic>S</italic>)-methylmalonyl-CoA derived propionate units (blue), one glyceryl-ACP (magenta), and one (2<italic>R</italic>)- methoxymalonyl-ACP (orange).</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s001.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s002"><label>S2 Fig</label><caption><title>Production of tetromadurin by <italic>Actinomadura verrucosospora</italic>.</title><p><bold>a,</bold>
<italic>A</italic>. <italic>verrucosospora</italic> grew on oatmeal agar as pale colonies that formed white hydrophobic spores after several days. <bold>b,</bold> Structure of tetromadurin (C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>), m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+NH<sub>4</sub>]<sup>+</sup> = 778.8; m/z [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+Na]<sup>+</sup> = 783.8. <bold>c,</bold> Top: total ion current (TIC) chromatogram of <italic>A</italic>. <italic>verrucosospora</italic> organic extract. A peak corresponding to tetromadurin [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+NH<sub>4</sub>]<sup>+</sup> (m/z = 778.8) was visible on the TIC at 19.8 min. Bottom: extracted m/z = 783.8 chromatogram of the tetromadurin sodium ion adduct [C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+Na]<sup>+</sup>
<bold>c,</bold> Mass spectrum of the tetromadurin peak from the TIC spectrum. *[C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+Na]<sup>+</sup>; **[C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+NH<sub>4</sub>]<sup>+</sup>; ***[C<sub>42</sub>H<sub>64</sub>O<sub>12</sub>+H]<sup>+</sup>. <bold>e,</bold> UV absorption spectrum of the tetromadurin peak. &#x003bb;<sub>MAX</sub> = 252 nm, 300 nm (MeOH), as previously reported [<xref rid="pone.0239054.ref001" ref-type="bibr">1</xref>].</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s002.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s003"><label>S3 Fig</label><caption><title>Alignment of the KS domains encoded in the tetromadurin biosynthetic gene cluster.</title><p>The KS domain of the loading module (MadAI_AT_LM) and each of the 14 extension modules (KS_1&#x02013;14) from the tetromadurin biosynthetic gene cluster were aligned using ClustalOmega[<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The amino acids of the C-H-H catalytic triad are highlighted with an asterisk (*). The KS domain of the loading module contains a glutamine in place of the catalytic cysteine (highlighted in yellow).</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s003.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s004"><label>S4 Fig</label><caption><title>Alignment of the AT domains encoded in the tetromadurin biosynthetic gene cluster.</title><p><bold>a,</bold> The AT domain of the loading module (MadAI_AT_LM) and each of the 14 extension modules (AT_1&#x02013;14) from the <italic>mad</italic> gene cluster were aligned using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The amino acid motif that predicts the selectivity of the AT domain is highlighted in either red (acetate-incorporating) or yellow (propionate-incorporating). <bold>b,</bold> The hypothetical linear tetromadurin intermediate predicted by retrobiosynthetic analysis. Propionate units derived from (2<italic>R</italic>)-methoxymalonyl-ACP are coloured in yellow. Acetate units derived from malonyl-CoA are coloured in red. The methoxy group predicted to arise from (2<italic>R</italic>)-methoxymalonyl-ACP is coloured in orange.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s004.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s005"><label>S5 Fig</label><caption><title>Alignment of the ER domains encoded in the tetromadurin biosynthetic gene cluster.</title><p><bold>a,</bold> The ER domains from the tetromadurin biosynthetic gene cluster were aligned using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The tyrosine residue associated with the <sc>l</sc>-configuration at the &#x003b1;-position in the product is marked with an asterisk (*). The ER domains are highlighted either yellow (producing <sc>l</sc>-configuration at the &#x003b1; position) or red (producing <sc>d</sc>-configuration at the &#x003b1; position). Only MadAII_ER_4 and MadAII_ER_11 affect the final stereochemistry of tetromadurin, as their respective modules incorporate a propionate unit with an &#x003b1; methyl group. <bold>b,</bold> The linear tetromadurin intermediate predicted from its final structure. The fully saturated carbon atoms (C9, C15, C23, and C27) produced by an ER domain are highlighted either in yellow (<sc>l</sc>-configuration-determining ER) or red (<sc>d</sc>-configuration-determining ER).</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s005.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s006"><label>S6 Fig</label><caption><title>Alignment of the DH domains encoded in the tetromadurin biosynthetic gene cluster.</title><p><bold>a,</bold> The DH domains of the extension modules 1&#x02013;13 from the <italic>mad</italic> gene cluster were aligned using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The tyrosine of the <bold>Y</bold>GP motif and the catalytic aspartic acid in the HPALL<bold>D</bold>AAL motif are marked with an asterisk (*). DH domains predicted to be active are highlighted in red and those predicted to be inactive are highlighted in yellow. <bold>b,</bold> The linear tetromadurin intermediate predicted from its final structure. The double bonds produced by DH domains are highlighted in red.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s006.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s007"><label>S7 Fig</label><caption><title>Alignment of the KR domains encoded in the tetromadurin biosynthetic gene cluster.</title><p><bold>a,</bold> The KR domains of the extension modules 1&#x02013;14 from the <italic>mad</italic> gene cluster were aligned using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The key features of a B1 type KR domain are highlighted: the (L/V/I)DD motif within the NADPH binding site (LDD), the catalytic tyrosine (*), and the locus of the proline found in A type KRs (P). All of the KR domains except KR_12 and KR_14 are predicted to be type B1. KR_12 and KR_14 both lacked the catalytic tyrosine residue, indicating they are inactive. KR_12 also had a significant deletion in its NADPH binding site. <bold>b,</bold> The linear tetromadurin intermediate predicted from its final structure. The three <sc>d</sc>-configured hydroxyls (C7, C17, and C21) predicted to form from a B1 type KR domain are highlighted in red. The <sc>d</sc> configuration of the methyl groups attached to C6 and C16 (C38 and C35, respectively) is also predicted to be governed by B1 type KRs. The KR domain in the position corresponding to the C7 hydroxyl (MadAVI_KR_12) appears to be inactive, so the origin of this hydroxyl is unknown.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s007.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s008"><label>S8 Fig</label><caption><title>Proposed biosynthesis of the tetromadurin tetronate ring.</title><p>The <italic>mad</italic> gene cluster contains the five genes of the glycerate-utilisation operon responsible for tetronate ring biosynthesis. The FkbH-like Mad7 catalyses likely formation of glyceryl-S-ACP using 1,3-bisphosphoglycerate and the ACP, Mad8. The FabH-like protein Mad16 then catalyses C-C and C-O bond formation to form the tetronate ring and release the polyketide chain from the PKS. Finally, the C40-C41 exocyclic double bond is formed <italic>via</italic> acetylation of the C41 hydroxyl by acetyltransferase Mad17, followed by elimination catalysed by the dehydratase Mad18. R = linear tetromadurin intermediate.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s008.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s009"><label>S9 Fig</label><caption><title>Proposed biosynthesis of (2<italic>R</italic>)-methoxymalonyl-ACP.</title><p>The FkbH-like Mad14 likely catalyses formation of glyceryl-ACP from 1,3 bisphosphoglycerate and the acyl-carrier protein Mad12. Glyceryl-ACP then undergoes two oxidation steps, catalysed by the dehydrogenases Mad11 and Mad13 to form (2<italic>R</italic>)-hydroxymalonyl-ACP, which is methylated by Mad15.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s009.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s010"><label>S10 Fig</label><caption><title>Proposed biosynthesis of the tetrahydrofuran rings in tetromadurin.</title><p>MadC catalyses the regio- and stereospecific epoxidation of the C24-C25 and C28-C29 <italic>E</italic> double bonds. Next, the MadB epoxide hydrolase catalyses two sequential <italic>exo</italic> ring-closures to form the two tetrahydrofuran rings.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s010.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s011"><label>S11 Fig</label><caption><title>Proposed biosynthesis of the cyclohexane and tetrahydropyran rings in tetromadurin.</title><p>Mad10 catalyses an inverse-electron demand hetero-Diels-Alder reaction to form oxadecalin-contain intermediate <bold>10</bold> from <bold>9</bold>. The equivalent oxadecalin from the tetronasin biosynthesis pathway, <bold>17</bold>, is hydrated to form a hemiacetal [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>], so the tetromadurin oxadecalin intermediate may do the same (forming <bold>11</bold>) given its structural similarity. Mad31 then catalyses a pericyclic rearrangement to form the tetrahydropyran ring and dismantle the cyclohexane ring, using the non-hemiacetal form of the oxadecalin intermediate <bold>10</bold> (as also predicted for tetronasin biosynthesis [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>]).</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s011.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s012"><label>S12 Fig</label><caption><title>Alignment of PyrE3-type [4+2] cyclases.</title><p>Protein sequence alignment of Mad10 (QKG20158 *see note in <xref ref-type="sec" rid="sec002">methods</xref> section relating to the revised sequence), Tmn9 (BAE93724), and Tsn11 (ACR50781) [<xref rid="pone.0239054.ref007" ref-type="bibr">7</xref>], the [4+2] cyclase TedJ (KYG52530) from the tetrodecamycin BGC [<xref rid="pone.0239054.ref067" ref-type="bibr">67</xref>], The [4+2] cyclase KijA (ACB46484) from the kijanimicin BGC [<xref rid="pone.0239054.ref045" ref-type="bibr">45</xref>]; The [4+2] cyclase PyrE3 (AFV71312) from the pyrroindomycin BGC [<xref rid="pone.0239054.ref042" ref-type="bibr">42</xref>]; The [4+2] cyclase VstK (BAQ21949) from the versipelostatin BGC [<xref rid="pone.0239054.ref046" ref-type="bibr">46</xref>], The [4+2] cyclase ChlE3 (AAZ77700) from the chlorothricin BGC [<xref rid="pone.0239054.ref048" ref-type="bibr">48</xref>]; The monooxygenase PgaE (AAK57522) from gaudimycin C biosynthesis [<xref rid="pone.0239054.ref050" ref-type="bibr">50</xref>]; The monooxygenase OxyS (4K2X_A) from oxytetracycline biosynthesis [<xref rid="pone.0239054.ref049" ref-type="bibr">49</xref>]; the monooxygenase MtmOIV (CAK50794) from mithramycin biosynthesis [<xref rid="pone.0239054.ref043" ref-type="bibr">43</xref>]. Red stars (<inline-formula id="pone.0239054.e001"><alternatives><graphic xlink:href="pone.0239054.e001.jpg" id="pone.0239054.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mrow><mml:mo mathcolor="FF0000">&#x02605;</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>) indicate amino acids involved in binding FAD [<xref rid="pone.0239054.ref049" ref-type="bibr">49</xref>]. Black asterisks (*) indicate the locations of the four arginine residues in MtmOIV involved in NADPH binding [<xref rid="pone.0239054.ref043" ref-type="bibr">43</xref>]. Similar residues in an alignment are coloured accordingly: Blue, hydrophobic; Green, polar; Purple, negative; Red, positive; Yellow, proline; Orange, glycine. Alignment was made using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>].</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s012.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s013"><label>S13 Fig</label><caption><title>Maximum likelihood phylogenetic tree of PyrE3 homologues.</title><p>A maximum likelihood phylogenetic tree was created for the diverse family of PyrE3 homologues, including: [4+2] cyclases from spirotetronate/tetramate pathways; FAD-dependent monooxygenases; and homologues from polyether tetronate pathways. 1000 bootstrap replicates were performed.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s013.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s014"><label>S14 Fig</label><caption><title>Alignment of VstJ-type [4+2] cyclases.</title><p>Protein sequence alignment of [4+2] cyclases encoded in the biosynthetic gene clusters of the polyether tetronates tetronasin (Tsn15: 6NOI_A), tetronomycin (Tmn8: BAF73716), and tetromadurin (Mad31: QKG20137); the spirotetronates abyssomicin (AbyU: 5DYV_A), versipelostatin (VstJ: BAQ21945), chlorothricin (ChlL: AAZ77701) and the spirotetramate pyrroindomycin (PyrI4: AFV71338). Similar residues in an alignment are coloured accordingly: Blue, hydrophobic; green, polar; purple, negative; red, positive; yellow, proline; orange, glycine. Alignment was made using ClustalOmega [<xref rid="pone.0239054.ref015" ref-type="bibr">15</xref>]. The (*) marks the conserved tryptophan.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s014.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s015"><label>S15 Fig</label><caption><title>Proposed cytochrome P450-catalysed hydroxylations in tetromadurin biosynthesis.</title><p>Mad29 is a homologue of the cytochrome P450 enzymes Tsn12 and Tmn14 present in the tetronasin and tetronomycin BGCs, respectively. We therefore propose that that Mad29 catalyses hydroxylation of C36, leaving Mad30 to hydroxylate C38.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s015.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s016"><label>S16 Fig</label><caption><title>Creation of the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 and <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad31 deletion mutants.</title><p>a, Creation of the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10. Left: Diagram showing the double crossing-over event between pYH7-<italic>mad10</italic> and the <italic>A</italic>. <italic>verrucosospora</italic> chromosome. In total 906/1404 bp of <italic>mad10</italic> were deleted in the &#x00394;mad10 mutant. The primers mad10_KO_Fw and mad10_KO_Rv were used to screen the genomic DNA of double crossover exconjugants to identify those containing the <italic>mad10</italic> coding-frame deletion. PCR product size wild type: 1913 bp. PCR product size &#x00394;mad10 mutant: 1007 bp. Right: Agarose gel demonstrating the successful creation of the <italic>A</italic>. <italic>verrucosospora</italic> &#x00394;mad10 mutant. b, Creation of the A. verrucosospora &#x00394;mad31 mutant. Left: Diagram showing the double crossing-over event between pYH7-<italic>mad31</italic> and the <italic>A</italic>. <italic>verrucosospora</italic> chromosome. In total 291/561 bp of <italic>mad31</italic> were deleted in the &#x00394;mad31 mutant. The primers mad31_KO_Fw and mad31_KO_Rv were used to screen the genomic DNA of double crossover exconjugants to identify those containing the &#x00394;mad31 coding-frame deletion. PCR product size wild type: 980 bp. PCR product size &#x00394;tsn15 mutant: 689 bp. Right: Agarose gel demonstrating the successful creation of a <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;mad31 mutant.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s016.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s017"><label>S17 Fig</label><caption><title>Creation of the <italic>S</italic>. sp NRRL 11266 &#x00394;tmn8 deletion mutant.</title><p>Left: Diagram showing the double crossing-over event between pYH7<italic>-tmn8</italic> and the <italic>S</italic>. sp NRRL 11266 chromosome. In total 573/573 bp of <italic>tmn8</italic> were deleted in the &#x00394;tmn8 mutant. The primers tmn8_KO_Fw and tmn8_KO_Rv were used to screen the genomic DNA of exconjugants to identify those in which the coding-frame deletion had taken place. PCR product size wild type: 971 bp. PCR product size &#x00394;tmn8 mutant: 398 bp. Left: Agarose gel demonstrating the successful creation of the <italic>S</italic>. sp NRRL 11266 &#x00394;tmn8 mutant.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s017.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s018"><label>S18 Fig</label><caption><title>HPLC-MS analysis of the <italic>Streptomyces</italic> sp. NRRL 11266 &#x00394;tmn8 mutant.</title><p><bold>a,</bold> The structure and molecular weight of tetronomycin (<bold>3</bold>) produced by <italic>S</italic>. sp. NRRL 11266. <bold>b,</bold> Extracted m/z = 609 chromatograms of <italic>S</italic>. sp. NRRL 11266 wild type (WT) and <italic>S</italic>. sp. NRRL 11266 &#x00394;tmn8. Tetronomycin <bold>3</bold> was detected in <italic>S</italic>. sp. NRRL 11266 WT as ammonium (m/z = 604.42) and sodium (m/z = 609.5) adducts. No tetronomycin production was detected from the <italic>S</italic>. sp. NRRL 11266 &#x00394;tmn8 mutant. Data are representative of three independent experiments.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s018.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0239054.s019"><label>S19 Fig</label><caption><title><italic>in vivo</italic> cross-complementation using <italic>tsn11</italic> and <italic>tsn15</italic> homologues.</title><p><bold>a,</bold> Genetic complementation of the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 mutant. I) Production of tetronasin <bold>2</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> WT. II) Production of <bold>17</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11. III) Production of <bold>17</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 pIB139-<italic>mad10</italic>. IV) Production of tetronasin <bold>2</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn11 pIB139-<italic>tsn11</italic>. Data are representative of three independent experiments. <bold>b,</bold> Genetic complementation of the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 mutant. I) Production of tetronasin <bold>2</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> WT. II) Lack of tetronasin production by the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 mutant. III) Lack of tetronasin production by the <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 pIB139-<italic>mad31</italic> mutant. IV) Production of tetronasin <bold>2</bold> by <italic>S</italic>. <italic>longisporoflavus</italic> &#x00394;tsn15 pIB139-<italic>tsn15</italic>. Data representative of three independent experiments.</p><p>(EPS)</p></caption><media xlink:href="pone.0239054.s019.eps"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors thank the DNA sequencing facility of the Department of Biochemistry, University of Cambridge, UK.</p></ack><ref-list><title>References</title><ref id="pone.0239054.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Hatsu</surname><given-names>M</given-names></name>, <name><surname>Sasaki</surname><given-names>T</given-names></name>, <name><surname>Miyadoh</surname><given-names>S</given-names></name>, <name><surname>Watabe</surname><given-names>H</given-names></name>, <name><surname>Takeuchi</surname><given-names>Y</given-names></name>, <name><surname>Kodama</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>SF2487, a new polyether antibiotic produced by <italic>Actinomadura</italic></article-title>. <source>J Antibiot</source>. <year>1990</year>; <volume>43</volume>:<fpage>259</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">2324011</pub-id></mixed-citation></ref><ref id="pone.0239054.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Hamill</surname><given-names>RL</given-names></name>, <name><surname>Yao</surname><given-names>RC-F</given-names></name>. <article-title>Antibiotic A80577 and process for its production</article-title> [Internet]. <fpage>EP0305086A3</fpage>, <year>1990</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://patents.google.com/patent/EP0305086A3/en">https://patents.google.com/patent/EP0305086A3/en</ext-link></mixed-citation></ref><ref id="pone.0239054.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Agtarap</surname><given-names>Amelia</given-names></name>, <name><surname>Chamberlin</surname><given-names>JW</given-names></name>, <name><surname>Pinkerton</surname><given-names>M</given-names></name>, <name><surname>Steinrauf</surname><given-names>LK</given-names></name>. <article-title>Structure of monensic acid, a new biologically active compound</article-title>. <source>J Am Chem Soc</source>. <year>1967</year>; <volume>89</volume>:<fpage>5737</fpage>&#x02013;<lpage>5739</lpage>.<pub-id pub-id-type="pmid">5622366</pub-id></mixed-citation></ref><ref id="pone.0239054.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Riddell</surname><given-names>FG</given-names></name>, <name><surname>Arumugam</surname><given-names>S</given-names></name>. <article-title>The transport of Li<sup>+</sup>, Na<sup>+</sup> and K<sup>+</sup> ions through phospholipid bilayers mediated by the antibiotic M139603 studied by <sup>7</sup>Li-, <sup>23</sup>Na- and <sup>39</sup>K-NMR</article-title>. <source>Biochim. Biophys. Acta (Biomembranes)</source>. <year>1989</year>; <volume>984</volume>:<fpage>6</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pone.0239054.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Grandjean</surname><given-names>J</given-names></name>, <name><surname>Laszlo</surname><given-names>P</given-names></name>. <article-title>Solution structure and cation-binding abilities of two quasi-isomorphous antibiotic ionophores, M139603 and tetronomycin</article-title>. <source>Tetrahedron Lett</source>. <year>1983</year>; <volume>24</volume>:<fpage>3319</fpage>&#x02013;<lpage>3322</lpage>.</mixed-citation></ref><ref id="pone.0239054.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Takeuchi</surname><given-names>T</given-names></name>, <name><surname>Wataya</surname><given-names>Y</given-names></name>, <name><surname>Iinuma</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>H-S</given-names></name>, <name><surname>Watabe</surname><given-names>H</given-names></name>, <name><surname>Naganawa</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Compositions for treating or preventing malaria and method of treating malaria</article-title>. <fpage>US6939892B2</fpage>, <year>2005</year> [cited 2018 Sep 28]. Available from: <ext-link ext-link-type="uri" xlink:href="https://patents.google.com/patent/US6939892B2/en">https://patents.google.com/patent/US6939892B2/en</ext-link></mixed-citation></ref><ref id="pone.0239054.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Little</surname><given-names>R</given-names></name>, <name><surname>Paiva</surname><given-names>FCR</given-names></name>, <name><surname>Jenkins</surname><given-names>R</given-names></name>, <name><surname>Hong</surname><given-names>H</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Demydchuk</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Unexpected enzyme-catalysed [4+2] cycloaddition and rearrangement in polyether antibiotic biosynthesis</article-title>. <source>Nat Catal</source>. <year>2019</year>; <volume>2</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pone.0239054.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Demydchuk</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Hong</surname><given-names>H</given-names></name>, <name><surname>Staunton</surname><given-names>J</given-names></name>, <name><surname>Spencer</surname><given-names>JB</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>. <article-title>Analysis of the Tetronomycin Gene Cluster: Insights into the biosynthesis of a polyether tetronate antibiotic</article-title>. <source>ChemBioChem</source>. <year>2008</year>; <volume>9</volume>:<fpage>1136</fpage>&#x02013;<lpage>1145</lpage>.<pub-id pub-id-type="pmid">18404760</pub-id></mixed-citation></ref><ref id="pone.0239054.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>C</given-names></name>, <name><surname>Donovan</surname><given-names>WP</given-names></name>, <name><surname>Shikapwashya-Hasser</surname><given-names>O</given-names></name>, <name><surname>Ye</surname><given-names>X</given-names></name>, <name><surname>Cole</surname><given-names>RH</given-names></name>. <article-title>Hot Fusion: An efficient method to clone multiple DNA Fragments as well as inverted repeats without ligase</article-title>. <source>PLOS ONE</source>. <year>2014</year>; <volume>9</volume>:<fpage>e115318</fpage>.<pub-id pub-id-type="pmid">25551825</pub-id></mixed-citation></ref><ref id="pone.0239054.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Wilkinson</surname><given-names>CJ</given-names></name>, <name><surname>Hughes-Thomas</surname><given-names>ZA</given-names></name>, <name><surname>Martin</surname><given-names>CJ</given-names></name>, <name><surname>B&#x000f6;hm</surname><given-names>I</given-names></name>, <name><surname>Mironenko</surname><given-names>T</given-names></name>, <name><surname>Deacon</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Increasing the efficiency of heterologous promoters in actinomycetes</article-title>. <source>J Mol Microbiol Biotechnol</source>. <year>2002</year>; <volume>4</volume>:<fpage>417</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">12125822</pub-id></mixed-citation></ref><ref id="pone.0239054.ref011"><label>11</label><mixed-citation publication-type="book"><name><surname>Kieser</surname><given-names>T</given-names></name>, <name><surname>Bibb</surname><given-names>MJ</given-names></name>, <name><surname>Buttner</surname><given-names>MJ</given-names></name>, <name><surname>Chater</surname><given-names>KF</given-names></name>, <name><surname>Hopwood</surname><given-names>DA</given-names></name>. <source>Practical <italic toggle="yes">streptomyces</italic> genetics</source>. <publisher-name>John Innes Foundation</publisher-name>; <year>2000</year>. 613 pp.</mixed-citation></ref><ref id="pone.0239054.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Le</surname><given-names>SQ</given-names></name>, <name><surname>Gascuel</surname><given-names>O</given-names></name>. <article-title>An improved general amino acid replacement matrix</article-title>. <source>Mol Biol Evol</source>. <year>2008</year>; <volume>25</volume>:<fpage>1307</fpage>&#x02013;<lpage>1320</lpage>.<pub-id pub-id-type="pmid">18367465</pub-id></mixed-citation></ref><ref id="pone.0239054.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Stecher</surname><given-names>G</given-names></name>, <name><surname>Tamura</surname><given-names>K</given-names></name>. <article-title>MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets</article-title>. <source>Mol Biol Evol</source>. <year>2016</year>; <volume>33</volume>:<fpage>1870</fpage>&#x02013;<lpage>1874</lpage>.<pub-id pub-id-type="pmid">27004904</pub-id></mixed-citation></ref><ref id="pone.0239054.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>BG</given-names></name>. <article-title>Building phylogenetic trees from molecular data with MEGA</article-title>. <source>Mol Biol Evol</source>. <year>2013</year>; <volume>30</volume>:<fpage>1229</fpage>&#x02013;<lpage>1235</lpage>.<pub-id pub-id-type="pmid">23486614</pub-id></mixed-citation></ref><ref id="pone.0239054.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Sievers</surname><given-names>F</given-names></name>, <name><surname>Wilm</surname><given-names>A</given-names></name>, <name><surname>Dineen</surname><given-names>D</given-names></name>, <name><surname>Gibson</surname><given-names>TJ</given-names></name>, <name><surname>Karplus</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Fast, scalable generation of high&#x02010;quality protein multiple sequence alignments using Clustal Omega</article-title>. <source>Mol Systems Biol</source>. <year>2011</year>; <volume>7</volume>:<fpage>539</fpage>.</mixed-citation></ref><ref id="pone.0239054.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Blin</surname><given-names>K</given-names></name>, <name><surname>Wolf</surname><given-names>T</given-names></name>, <name><surname>Chevrette</surname><given-names>MG</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Schwalen</surname><given-names>CJ</given-names></name>, <name><surname>Kautsar</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>antiSMASH 4.0-improvements in chemistry prediction and gene cluster boundary identification</article-title>. <source>Nucleic Acids Res</source>. <year>2017</year>; <volume>45</volume>(<issue>W1</issue>):<fpage>W36</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">28460038</pub-id></mixed-citation></ref><ref id="pone.0239054.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Altschul</surname><given-names>SF</given-names></name>, <name><surname>Gish</surname><given-names>W</given-names></name>, <name><surname>Miller</surname><given-names>W</given-names></name>, <name><surname>Myers</surname><given-names>EW</given-names></name>, <name><surname>Lipman</surname><given-names>DJ</given-names></name>. <article-title>Basic local alignment search tool</article-title>. <source>J Mol Biol</source>. <year>1990</year>; <volume>215</volume>:<fpage>403</fpage>&#x02013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="pone.0239054.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Vieweg</surname><given-names>L</given-names></name>, <name><surname>Reichau</surname><given-names>S</given-names></name>, <name><surname>Schobert</surname><given-names>R</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>, <name><surname>S&#x000fc;ssmuth</surname><given-names>RD</given-names></name>. <article-title>Recent advances in the field of bioactive tetronates</article-title>. <source>Nat Prod Rep</source>. <year>2014</year>; <volume>31</volume>:<fpage>1554</fpage>&#x02013;<lpage>1584</lpage>.<pub-id pub-id-type="pmid">24965099</pub-id></mixed-citation></ref><ref id="pone.0239054.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Keatinge-Clay</surname><given-names>AT</given-names></name>. <article-title>The structures of type I polyketide synthases</article-title>. <source>Nat Prod Rep</source>. <year>2012</year>; <volume>29</volume>:<fpage>1050</fpage>&#x02013;<lpage>1073</lpage>.<pub-id pub-id-type="pmid">22858605</pub-id></mixed-citation></ref><ref id="pone.0239054.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Long</surname><given-names>PF</given-names></name>, <name><surname>Wilkinson</surname><given-names>CJ</given-names></name>, <name><surname>Bisang</surname><given-names>CP</given-names></name>, <name><surname>Cort&#x000e9;s</surname><given-names>J</given-names></name>, <name><surname>Dunster</surname><given-names>N</given-names></name>, <name><surname>Oliynyk</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Engineering specificity of starter unit selection by the erythromycin-producing polyketide synthase</article-title>. <source>Mol Microbiol</source>. <year>2002</year>; <volume>43</volume>:<fpage>1215</fpage>&#x02013;<lpage>1225</lpage>.<pub-id pub-id-type="pmid">11918808</pub-id></mixed-citation></ref><ref id="pone.0239054.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Haydock</surname><given-names>SF</given-names></name>, <name><surname>Aparicio</surname><given-names>JF</given-names></name>, <name><surname>Moln&#x000e1;r</surname><given-names>I</given-names></name>, <name><surname>Schwecke</surname><given-names>T</given-names></name>, <name><surname>Khaw</surname><given-names>LE</given-names></name>, <name><surname>K&#x000f6;nig</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Divergent sequence motifs correlated with the substrate specificity of (methyl)malonyl-CoA:acyl carrier protein transacylase domains in modular polyketide synthases</article-title>. <source>FEBS Lett</source>. <year>1995</year>; <volume>374</volume>:<fpage>246</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">7589545</pub-id></mixed-citation></ref><ref id="pone.0239054.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Del Vecchio</surname><given-names>F</given-names></name>, <name><surname>Petkovic</surname><given-names>H</given-names></name>, <name><surname>Kendrew</surname><given-names>SG</given-names></name>, <name><surname>Low</surname><given-names>L</given-names></name>, <name><surname>Wilkinson</surname><given-names>B</given-names></name>, <name><surname>Lill</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Active-site residue, domain and module swaps in modular polyketide synthases</article-title>. <source>J Ind Microbiol Biotechnol</source>. <year>2003</year>; <volume>30</volume>:<fpage>489</fpage>&#x02013;<lpage>494</lpage>.<pub-id pub-id-type="pmid">12811585</pub-id></mixed-citation></ref><ref id="pone.0239054.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Petkovi&#x00107;</surname><given-names>H</given-names></name>, <name><surname>Sandmann</surname><given-names>A</given-names></name>, <name><surname>Challis</surname><given-names>IR</given-names></name>, <name><surname>Hecht</surname><given-names>H-J</given-names></name>, <name><surname>Silakowski</surname><given-names>B</given-names></name>, <name><surname>Low</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Substrate specificity of the acyl transferase domains of EpoC from the epothilone polyketide synthase</article-title>. <source>Org Biomol Chem</source>. <year>2008</year>; <volume>6</volume>:<fpage>500</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">18219420</pub-id></mixed-citation></ref><ref id="pone.0239054.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>K</given-names></name>, <name><surname>Chung</surname><given-names>L</given-names></name>, <name><surname>Revill</surname><given-names>WP</given-names></name>, <name><surname>Katz</surname><given-names>L</given-names></name>, <name><surname>Reeves</surname><given-names>CD</given-names></name>. <article-title>The FK520 gene cluster of <italic>Streptomyces hygroscopicus</italic> var. <italic>ascomyceticus</italic> (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units</article-title>. <source>Gene</source>
<year>2000</year>; <volume>251</volume>:<fpage>81</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">10863099</pub-id></mixed-citation></ref><ref id="pone.0239054.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Kwan</surname><given-names>DH</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Schulz</surname><given-names>F</given-names></name>, <name><surname>Hong</surname><given-names>H</given-names></name>, <name><surname>Popovic</surname><given-names>B</given-names></name>, <name><surname>Sim-Stark</surname><given-names>JCC</given-names></name>, <etal>et al</etal>
<article-title>Prediction and manipulation of the stereochemistry of enoylreduction in modular polyketide synthases</article-title>. <source>Chem Biol</source>. <year>2008</year>; <volume>15</volume>:<fpage>1231</fpage>&#x02013;<lpage>1240</lpage>.<pub-id pub-id-type="pmid">19022183</pub-id></mixed-citation></ref><ref id="pone.0239054.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Hashimoto</surname><given-names>T</given-names></name>, <name><surname>Qin</surname><given-names>B</given-names></name>, <name><surname>Hashimoto</surname><given-names>J</given-names></name>, <name><surname>Kozone</surname><given-names>I</given-names></name>, <name><surname>Kawahara</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Characterization of giant modular PKSs provides insight into genetic mechanism for structural diversification of aminopolyol polyketides</article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2017</year>; <volume>56</volume>:<fpage>1740</fpage>&#x02013;<lpage>1745</lpage>.<pub-id pub-id-type="pmid">28133950</pub-id></mixed-citation></ref><ref id="pone.0239054.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Keatinge-Clay</surname><given-names>AT</given-names></name>. <article-title>A tylosin ketoreductase reveals how chirality is determined in polyketides</article-title>. <source>Chem Biol</source>. <year>2007</year>; <volume>14</volume>:<fpage>898</fpage>&#x02013;<lpage>908</lpage>.<pub-id pub-id-type="pmid">17719489</pub-id></mixed-citation></ref><ref id="pone.0239054.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Caffrey</surname><given-names>P</given-names></name>. <article-title>Conserved amino acid residues correlating with ketoreductase stereospecificity in modular polyketide synthases</article-title>. <source>ChemBioChem</source>. <year>2003</year>; <volume>4</volume>:<fpage>654</fpage>&#x02013;<lpage>657</lpage>.<pub-id pub-id-type="pmid">12851937</pub-id></mixed-citation></ref><ref id="pone.0239054.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Reid</surname><given-names>R</given-names></name>, <name><surname>Piagentini</surname><given-names>M</given-names></name>, <name><surname>Rodriguez</surname><given-names>E</given-names></name>, <name><surname>Ashley</surname><given-names>G</given-names></name>, <name><surname>Viswanathan</surname><given-names>N</given-names></name>, <name><surname>Carney</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>A model of structure and catalysis for ketoreductase domains in modular polyketide synthases</article-title>. <source>Biochemistry</source>. <year>2003</year>; <volume>42</volume>:<fpage>72</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">12515540</pub-id></mixed-citation></ref><ref id="pone.0239054.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Hahn</surname><given-names>F</given-names></name>, <name><surname>Demydchuk</surname><given-names>Y</given-names></name>, <name><surname>Chettle</surname><given-names>J</given-names></name>, <name><surname>Tosin</surname><given-names>M</given-names></name>, <name><surname>Osada</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title><italic>In vitro</italic> reconstruction of tetronate RK-682 biosynthesis</article-title>. <source>Nat Chem Biol</source>. <year>2010</year>; <volume>6</volume>:<fpage>99</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">20081823</pub-id></mixed-citation></ref><ref id="pone.0239054.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Kanchanabanca</surname><given-names>C</given-names></name>, <name><surname>Tao</surname><given-names>W</given-names></name>, <name><surname>Hong</surname><given-names>H</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Hahn</surname><given-names>F</given-names></name>, <name><surname>Samborskyy</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Unusual acetylation&#x02013;elimination in the formation of tetronate antibiotics</article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2013</year>; <volume>52</volume>:<fpage>5785</fpage>&#x02013;<lpage>5788</lpage>.<pub-id pub-id-type="pmid">23606658</pub-id></mixed-citation></ref><ref id="pone.0239054.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>YA</given-names></name>, <name><surname>Podevels</surname><given-names>AM</given-names></name>, <name><surname>Kevany</surname><given-names>BM</given-names></name>, <name><surname>Thomas</surname><given-names>MG</given-names></name>. <article-title>Biosynthesis of polyketide synthase extender units</article-title>. <source>Nat Prod Rep</source>. <year>2009</year>; <volume>26</volume>:<fpage>90</fpage>&#x02013;<lpage>114</lpage>.<pub-id pub-id-type="pmid">19374124</pub-id></mixed-citation></ref><ref id="pone.0239054.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Ju</surname><given-names>J</given-names></name>, <name><surname>Rajski</surname><given-names>SR</given-names></name>, <etal>et al</etal>
<article-title>Characterization of the tautomycin biosynthetic gene cluster from <italic>Streptomyces spiroverticillatus</italic> unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>
<year>2008</year>; <volume>283</volume>: <fpage>28607</fpage>&#x02013;<lpage>28617</lpage>.<pub-id pub-id-type="pmid">18708355</pub-id></mixed-citation></ref><ref id="pone.0239054.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>C</given-names></name>, <name><surname>Coughlin</surname><given-names>JM</given-names></name>, <name><surname>Ju</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Oxazolomycin biosynthesis in <italic>Streptomyces albus</italic> JA3453 featuring an &#x02018;acyltransferase-less&#x02019; type I polyketide synthase that incorporates two distinct extender units</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>
<year>2010</year>; <volume>285</volume>: <fpage>20097</fpage>&#x02013;<lpage>20108</lpage>.<pub-id pub-id-type="pmid">20406823</pub-id></mixed-citation></ref><ref id="pone.0239054.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Rascher</surname><given-names>A</given-names></name>, <name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Viswanathan</surname><given-names>N</given-names></name>, <name><surname>Schirmer</surname><given-names>A</given-names></name>, <name><surname>Reid</surname><given-names>R</given-names></name>, <name><surname>Nierman</surname><given-names>WC</given-names></name>, <etal>et al</etal>
<article-title>Cloning and characterization of a gene cluster for geldanamycin production in <italic>Streptomyces hygroscopicus</italic> NRRL 3602</article-title>. <source>FEMS Microbiol Lett</source>. <year>2003</year>; <volume>218</volume>:<fpage>223</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">12586396</pub-id></mixed-citation></ref><ref id="pone.0239054.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Rascher</surname><given-names>A</given-names></name>, <name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Buchanan</surname><given-names>GO</given-names></name>, <name><surname>Reid</surname><given-names>R</given-names></name>, <name><surname>Hutchinson</surname><given-names>CR</given-names></name>. <article-title>Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption</article-title>. <source>Appl Environ Microbiol</source>. <year>2005</year>; <volume>71</volume>:<fpage>4862</fpage>&#x02013;<lpage>4871</lpage>.<pub-id pub-id-type="pmid">16085885</pub-id></mixed-citation></ref><ref id="pone.0239054.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Wenzel</surname><given-names>SC</given-names></name>, <name><surname>Williamson</surname><given-names>RM</given-names></name>, <name><surname>Gr&#x000fc;nanger</surname><given-names>C</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Gerth</surname><given-names>K</given-names></name>, <name><surname>Martinez</surname><given-names>RA</given-names></name>, <etal>et al</etal>
<article-title>On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate for incorporation of &#x0201c;glycolate&#x0201d; units into ansamitocin and soraphen A</article-title>. <source>J Am Chem Soc</source>. <year>2006</year>; <volume>128</volume>:<fpage>14325</fpage>&#x02013;<lpage>14336</lpage>.<pub-id pub-id-type="pmid">17076505</pub-id></mixed-citation></ref><ref id="pone.0239054.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Gallimore</surname><given-names>AR</given-names></name>, <name><surname>Stark</surname><given-names>CBW</given-names></name>, <name><surname>Bhatt</surname><given-names>A</given-names></name>, <name><surname>Harvey</surname><given-names>BM</given-names></name>, <name><surname>Demydchuk</surname><given-names>Y</given-names></name>, <name><surname>Bolanos-Garcia</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Evidence for the role of the monB genes in polyether ring formation during monensin biosynthesis</article-title>. <source>Chem Biol</source>. <year>2006</year>; <volume>13</volume>:<fpage>453</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">16632258</pub-id></mixed-citation></ref><ref id="pone.0239054.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Harvey</surname><given-names>BM</given-names></name>, <name><surname>Mironenko</surname><given-names>T</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Hong</surname><given-names>H</given-names></name>, <name><surname>Deng</surname><given-names>Z</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>, <etal>et al</etal>
<article-title>Insights into polyether biosynthesis from analysis of the nigericin biosynthetic gene cluster in <italic>Streptomyces</italic> sp. DSM4137</article-title>. <source>Chem Biol</source>. <year>2007</year>; <volume>14</volume>:<fpage>703</fpage>&#x02013;<lpage>714</lpage>.<pub-id pub-id-type="pmid">17584617</pub-id></mixed-citation></ref><ref id="pone.0239054.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Cane</surname><given-names>DE</given-names></name>, <name><surname>Liang</surname><given-names>T-C</given-names></name>, <name><surname>Hasler</surname><given-names>H</given-names></name>. <article-title>Polyether biosynthesis. Origin of the oxygen atoms of monensin A</article-title>. <source>J Am Chem Soc</source>. <year>1981</year>; <volume>103</volume>:<fpage>5962</fpage>&#x02013;<lpage>5965</lpage>.</mixed-citation></ref><ref id="pone.0239054.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Tosin</surname><given-names>M</given-names></name>, <name><surname>Smith</surname><given-names>L</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>. <article-title>Insights into lasalocid A ring formation by chemical chain termination <italic>in vivo</italic></article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2011</year>; <volume>50</volume>:<fpage>11930</fpage>&#x02013;<lpage>11933</lpage>.<pub-id pub-id-type="pmid">22025396</pub-id></mixed-citation></ref><ref id="pone.0239054.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>Z</given-names></name>, <name><surname>Sun</surname><given-names>P</given-names></name>, <name><surname>Yan</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Zheng</surname><given-names>Q</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>An enzymatic [4+2] cyclization cascade creates the pentacyclic core of pyrroindomycins</article-title>. <source>Nat Chem Biol</source>. <year>2015</year>; <volume>11</volume>:<fpage>259</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">25730548</pub-id></mixed-citation></ref><ref id="pone.0239054.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Bosserman</surname><given-names>MA</given-names></name>, <name><surname>Downey</surname><given-names>T</given-names></name>, <name><surname>Noinaj</surname><given-names>N</given-names></name>, <name><surname>Buchanan</surname><given-names>SK</given-names></name>, <name><surname>Rohr</surname><given-names>J</given-names></name>. <article-title>Molecular insight into substrate recognition and catalysis of Baeyer&#x02013;Villiger monooxygenase MtmOIV, the key frame-modifying enzyme in the biosynthesis of anticancer agent mithramycin</article-title>. <source>ACS Chem Biol</source>. <year>2013</year>; <volume>8</volume>:<fpage>2466</fpage>&#x02013;<lpage>2477</lpage>.<pub-id pub-id-type="pmid">23992662</pub-id></mixed-citation></ref><ref id="pone.0239054.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>Q</given-names></name>, <name><surname>Gong</surname><given-names>Y</given-names></name>, <name><surname>Guo</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Zhou</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Structural insights into a flavin-dependent [4+2] cyclase that catalyzes trans-decalin formation in pyrroindomycin biosynthesis</article-title>. <source>Cell Chem Biol</source>. <year>2018</year>; <volume>25</volume>:<fpage>718</fpage>&#x02013;<lpage>727.e3</lpage>.<pub-id pub-id-type="pmid">29657086</pub-id></mixed-citation></ref><ref id="pone.0239054.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>White-Phillip</surname><given-names>JA</given-names></name>, <name><surname>Melan&#x000e7;on</surname><given-names>CE</given-names></name>, <name><surname>Kwon</surname><given-names>H</given-names></name>, <name><surname>Yu</surname><given-names>W</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>. <article-title>Elucidation of the kijanimicin gene cluster:&#x02009; insights into the biosynthesis of spirotetronate antibiotics and nitrosugars</article-title>. <source>J Am Chem Soc</source>. <year>2007</year>; <volume>129</volume>:<fpage>14670</fpage>&#x02013;<lpage>14683</lpage>.<pub-id pub-id-type="pmid">17985890</pub-id></mixed-citation></ref><ref id="pone.0239054.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Hashimoto</surname><given-names>T</given-names></name>, <name><surname>Hashimoto</surname><given-names>J</given-names></name>, <name><surname>Teruya</surname><given-names>K</given-names></name>, <name><surname>Hirano</surname><given-names>T</given-names></name>, <name><surname>Shin-ya</surname><given-names>K</given-names></name>, <name><surname>Ikeda</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Biosynthesis of versipelostatin: identification of an enzyme-catalyzed [4+2]-cycloaddition required for macrocyclization of spirotetronate-containing polyketides</article-title>. <source>J Am Chem Soc</source>. <year>2015</year>; <volume>137</volume>:<fpage>572</fpage>&#x02013;<lpage>575</lpage>.<pub-id pub-id-type="pmid">25551461</pub-id></mixed-citation></ref><ref id="pone.0239054.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Gverzdys</surname><given-names>T</given-names></name>, <name><surname>Nodwell</surname><given-names>JR</given-names></name>. <article-title>Biosynthetic genes for the tetrodecamycin antibiotics</article-title>. <source>J Bacteriol</source>. <year>2016</year>; <volume>198</volume>:<fpage>1965</fpage>&#x02013;<lpage>1973</lpage>.<pub-id pub-id-type="pmid">27137499</pub-id></mixed-citation></ref><ref id="pone.0239054.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Jia</surname><given-names>X-Y</given-names></name>, <name><surname>Tian</surname><given-names>Z-H</given-names></name>, <name><surname>Shao</surname><given-names>L</given-names></name>, <name><surname>Qu</surname><given-names>X-D</given-names></name>, <name><surname>Zhao</surname><given-names>Q-F</given-names></name>, <name><surname>Tang</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Genetic characterization of the chlorothricin gene cluster as a model for spirotetronate antibiotic biosynthesis</article-title>. <source>Chem Biol</source>. <year>2006</year>; <volume>13</volume>:<fpage>575</fpage>&#x02013;<lpage>585</lpage>.<pub-id pub-id-type="pmid">16793515</pub-id></mixed-citation></ref><ref id="pone.0239054.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>P</given-names></name>, <name><surname>Bashiri</surname><given-names>G</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Sawaya</surname><given-names>MR</given-names></name>, <name><surname>Tang</surname><given-names>Y</given-names></name>. <article-title>Uncovering the enzymes that catalyze the final steps in oxytetracycline biosynthesis</article-title>. <source>J Am Chem Soc</source>. <year>2013</year>; <volume>135</volume>:<fpage>7138</fpage>&#x02013;<lpage>7141</lpage>.<pub-id pub-id-type="pmid">23621493</pub-id></mixed-citation></ref><ref id="pone.0239054.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Kallio</surname><given-names>P</given-names></name>, <name><surname>Patrikainen</surname><given-names>P</given-names></name>, <name><surname>Belogurov</surname><given-names>GA</given-names></name>, <name><surname>M&#x000e4;nts&#x000e4;l&#x000e4;</surname><given-names>P</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Niemi</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Tracing the evolution of angucyclinone monooxygenases: structural determinants for C-12b hydroxylation and substrate inhibition in PgaE</article-title>. <source>Biochemistry</source>
<year>2013</year>; <volume>52</volume>:<fpage>4507</fpage>&#x02013;<lpage>4516</lpage>.<pub-id pub-id-type="pmid">23731237</pub-id></mixed-citation></ref><ref id="pone.0239054.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>L-K</given-names></name>, <name><surname>Abdelwahab</surname><given-names>H</given-names></name>, <name><surname>Campo</surname><given-names>JSMD</given-names></name>, <name><surname>Mehra-Chaudhary</surname><given-names>R</given-names></name>, <name><surname>Sobrado</surname><given-names>P</given-names></name>, <name><surname>Tanner</surname><given-names>JJ</given-names></name>. <article-title>The structure of the antibiotic deactivating, N-hydroxylating rifampicin monooxygenase</article-title>. <source>J Biol Chem</source>. <year>2016</year>; <volume>291</volume>:<fpage>21553</fpage>&#x02013;<lpage>21562</lpage>.<pub-id pub-id-type="pmid">27557658</pub-id></mixed-citation></ref><ref id="pone.0239054.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Sheldon</surname><given-names>PJ</given-names></name>, <name><surname>Busarow</surname><given-names>SB</given-names></name>, <name><surname>Hutchinson</surname><given-names>CR</given-names></name>. <article-title>Mapping the DNA-binding domain and target sequences of the <italic>Streptomyces peucetius</italic> daunorubicin biosynthesis regulatory protein, DnrI</article-title>. <source>Mol Microbiol</source>. <year>2002</year>; <volume>44</volume>:<fpage>449</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">11972782</pub-id></mixed-citation></ref><ref id="pone.0239054.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Wietzorrek</surname><given-names>A</given-names></name>, <name><surname>Bibb</surname><given-names>M</given-names></name>. <article-title>A novel family of proteins that regulates antibiotic production in streptomycetes appears to contain an OmpR-like DNA-binding fold</article-title>. <source>Mol Microbiol</source>. <year>1997</year>; <volume>25</volume>:<fpage>1181</fpage>&#x02013;<lpage>1184</lpage>.<pub-id pub-id-type="pmid">9350875</pub-id></mixed-citation></ref><ref id="pone.0239054.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Xie</surname><given-names>J</given-names></name>. <article-title>Role and regulation of bacterial LuxR-like regulators</article-title>. <source>Journal of Cellular Biochemistry</source>
<year>2011</year>; <volume>112</volume>:<fpage>2694</fpage>&#x02013;<lpage>2702</lpage>.<pub-id pub-id-type="pmid">21678467</pub-id></mixed-citation></ref><ref id="pone.0239054.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Alekshun</surname><given-names>MN</given-names></name>, <name><surname>Levy</surname><given-names>SB</given-names></name>. <article-title>The mar regulon: multiple resistance to antibiotics and other toxic chemicals</article-title>. <source>Trends Microbiol</source>. <year>1999</year>; <volume>7</volume>:<fpage>410</fpage>&#x02013;<lpage>413</lpage>.<pub-id pub-id-type="pmid">10498949</pub-id></mixed-citation></ref><ref id="pone.0239054.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Wilkens</surname><given-names>S</given-names></name>. <article-title>Structure and mechanism of ABC transporters</article-title>. <source>F1000Prime Rep</source>. <year>2015</year>;<volume>7</volume> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338842/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338842/</ext-link></mixed-citation></ref><ref id="pone.0239054.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Linton</surname><given-names>KJ</given-names></name>, <name><surname>Cooper</surname><given-names>HN</given-names></name>, <name><surname>Hunter</surname><given-names>LS</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>. <article-title>An ABC-transporter from <italic>Streptomyces longisporoflavus</italic> confers resistance to the polyether-ionophore antibiotic tetronasin</article-title>. <source>Mol Microbiol</source>. <year>1994</year>; <volume>11</volume>:<fpage>777</fpage>&#x02013;<lpage>785</lpage>.<pub-id pub-id-type="pmid">8196549</pub-id></mixed-citation></ref><ref id="pone.0239054.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Deochand</surname><given-names>DK</given-names></name>, <name><surname>Grove</surname><given-names>A</given-names></name>. <article-title>MarR family transcription factors: dynamic variations on a common scaffold</article-title>. <source>Crit Rev Biochem Mol Biol</source>. <year>2017</year>; <volume>52</volume>:<fpage>595</fpage>&#x02013;<lpage>613</lpage>.<pub-id pub-id-type="pmid">28670937</pub-id></mixed-citation></ref><ref id="pone.0239054.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Daduang</surname><given-names>R</given-names></name>, <name><surname>Kitani</surname><given-names>S</given-names></name>, <name><surname>Hashimoto</surname><given-names>J</given-names></name>, <name><surname>Thamchaipenet</surname><given-names>A</given-names></name>, <name><surname>Igarashi</surname><given-names>Y</given-names></name>, <name><surname>Shin-ya</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Characterization of the biosynthetic gene cluster for maklamicin, a spirotetronate-class antibiotic of the endophytic <italic>Micromonospora</italic> sp. NBRC 110955</article-title>. <source>Microbiol Res</source>. <year>2015</year>; <volume>180</volume>:<fpage>30</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">26505309</pub-id></mixed-citation></ref><ref id="pone.0239054.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Murugan</surname><given-names>E</given-names></name>, <name><surname>Kong</surname><given-names>R</given-names></name>, <name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Rao</surname><given-names>F</given-names></name>, <name><surname>Liang</surname><given-names>Z-X</given-names></name>. <article-title>Expression, purification and characterization of the acyl carrier protein phosphodiesterase from <italic>Pseudomonas Aeruginosa</italic></article-title>. <source>Protein expression and purification</source>. <year>2010</year>; <volume>71</volume>:<fpage>132</fpage>&#x02013;<lpage>138</lpage>.<pub-id pub-id-type="pmid">20064615</pub-id></mixed-citation></ref><ref id="pone.0239054.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Cronan</surname><given-names>JE</given-names></name>, <name><surname>Thomas</surname><given-names>J</given-names></name>. <article-title>Bacterial fatty acid synthesis and its relationships with polyketide synthetic pathways</article-title>. <source>Methods Enzymol</source>. <year>2009</year>; <volume>459</volume>:<fpage>395</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">19362649</pub-id></mixed-citation></ref><ref id="pone.0239054.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Heathcote</surname><given-names>ML</given-names></name>, <name><surname>Staunton</surname><given-names>J</given-names></name>, <name><surname>Leadlay</surname><given-names>PF</given-names></name>. <article-title>Role of type II thioesterases: evidence for removal of short acyl chains produced by aberrant decarboxylation of chain extender units</article-title>. <source>Chem Biol</source>. <year>2001</year>; <volume>8</volume>:<fpage>207</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">11251294</pub-id></mixed-citation></ref><ref id="pone.0239054.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Kotowska</surname><given-names>M</given-names></name>, <name><surname>Pawlik</surname><given-names>K</given-names></name>. <article-title>Roles of type II thioesterases and their application for secondary metabolite yield improvement</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2014</year>; <volume>98</volume>:<fpage>7735</fpage>&#x02013;<lpage>7746</lpage>.<pub-id pub-id-type="pmid">25081554</pub-id></mixed-citation></ref><ref id="pone.0239054.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Katsuyama</surname><given-names>Y</given-names></name>, <name><surname>Ohnishi</surname><given-names>Y</given-names></name>. <article-title>Chapter Sixteen&#x02014;Type III polyketide synthases in microorganisms</article-title>. <source>Methods Enzymol</source>. <year>2012</year>; <volume>505</volume>:<fpage>359</fpage>&#x02013;<lpage>377</lpage>.</mixed-citation></ref><ref id="pone.0239054.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Weissman</surname><given-names>KJ</given-names></name>. <article-title>Uncovering the structures of modular polyketide synthases</article-title>. <source>Nat Prod Rep</source>. <year>2015</year>; <volume>32</volume>:<fpage>436</fpage>&#x02013;<lpage>453</lpage>.<pub-id pub-id-type="pmid">25310997</pub-id></mixed-citation></ref><ref id="pone.0239054.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Du</surname><given-names>L</given-names></name>. <article-title>Iterative polyketide biosynthesis by modular polyketide synthases in bacteria</article-title>. <source>Appl Microbiol Biotechnol</source>. <year>2015</year>; <volume>100</volume>:<fpage>541</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">26549236</pub-id></mixed-citation></ref><ref id="pone.0239054.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Gverzdys</surname><given-names>T</given-names></name>, <name><surname>Kramer</surname><given-names>G</given-names></name>, <name><surname>Nodwell</surname><given-names>JR</given-names></name>. <article-title>Tetrodecamycin: An unusual and interesting tetronate antibiotic</article-title>. <source>Bioorg Med Chem</source>. <year>2016</year>; <volume>24</volume>:<fpage>6269</fpage>&#x02013;<lpage>6275</lpage>.<pub-id pub-id-type="pmid">27246856</pub-id></mixed-citation></ref></ref-list></back><sub-article id="pone.0239054.r001" article-type="aggregated-review-documents"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0239054.r001</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Boddy</surname><given-names>Christopher N.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Christopher N. Boddy</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Christopher N. Boddy</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pone.0239054" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">20 May 2020</named-content>
</p><p>PONE-D-20-10863</p><p>The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic.</p><p>PLOS ONE</p><p>Dear Dr Little,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x02019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>We would appreciate receiving your revised manuscript by Jul 04 2020 11:59PM. When you are ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.</p><p>To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols">http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link></p><p>Please include the following items when submitting your revised manuscript:</p><p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.</p></list-item></list></p><p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Christopher N. Boddy, Ph.D.</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal Requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p><p>2. We note you have included tables to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables 1, 2 and 3 in your text; if accepted, production will need this reference to link the reader to the Tables.</p><p>Additional Editor Comments (if provided):</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p><bold>Comments to the Author</bold></p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1: Yes</p><p>Reviewer #2: Yes</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1: Yes</p><p>Reviewer #2: Yes</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link ext-link-type="uri" xlink:href="http://www.plosone.org/static/policies.action#sharing">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x02014;e.g. participant privacy or use of data from a third party&#x02014;those must be specified.</p><p>Reviewer #1: Yes</p><p>Reviewer #2: Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1: Yes</p><p>Reviewer #2: Yes</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1: This manuscript describes the identification and characterization of the biosynthetic gene cluster for tetromadurin from Actinomadura verrucosispora. The authors present a thorough biosynthetic proposal based upon bioinformatic analysis of the gene cluster alongside several strategic gene inactivation experiments. Comparisons are drawn to the previously studied tetronasin and tetronomycin pathways.</p><p>The manuscript is well written with only a couple of very minor typographic errors and describes sound, high quality experimental research.</p><p>Publication is recommended after these minor changes.</p><p>Line 81-83: How were the necessary building blocks determined? Was this previously reported? Based on labelling experiments? Or is this a prediction?</p><p>Line 192: Add information about the MS parameters used for HPLC-MS analysis</p><p>Line 213-214: Include information in methods section about how the Actinomadura verrucosispora was sequenced. Include gDNA isolation and sequencing preparation steps as well as genome assembly information. If this was carried out by a service, state which company/lab</p><p>Figures 4/5: would benefit from using colour to highlight chemical changes in the structures. Also hard to read the writing inside circles in Fig 4, remove shading in circles.</p><p>Line 282-285: These two sentences feel out of place a confusing. Either remove entirely or rephrase and move to after the description of the PKS genes that are present.</p><p>Line 300-303: The use of the term &#x0201c;predicted&#x0201d; to describe both of the structures in Fig 6 caption is confusing and inconsistent with the statement in line 292-294 in the text. Please clarify language</p><p>Line 421: Change &#x0201c;(Fig 8c)&#x0201d; to &#x0201c;(Fig 9c)&#x0201d;</p><p>Line 500-502: Can you really use this argument if the complementation worked for Mad10 using the same vector?</p><p>Line 533: Change &#x0201c;Fig 7&#x0201d; to &#x0201c;Fig 8&#x0201d;</p><p>Line 756: Change &#x0201c;oolyether&#x0201d; to &#x0201c;polyether&#x0201d;</p><p>Reviewer #2: Little et al identified the biosynthetic gene cluster involved in polyether compound tetromadurin biosynthesis in Actinomadura verrucosispora. They did bioinformatic analysis and performed gene deletions (cyclase genes mad10 and mad31) to confirm the involvement of this cluster in tetromadurin biosynthesis. The overall writing is clear. The following issues are suggested to be addressed:</p><p>The biggest issue is that the novel tetromadurin analogue produced by &#x00394;mad10 was not purified and identified by NMR analysis.</p><p>Fig 4, 5: please combine these two figures. For Fig 4, I would like to suggest the authors to use different colors to indicate the specificities of the ATs.</p><p>Fig 6: It is more appropriate to remove Fig 6 to supporting information as this product is predicted via bioinformatics analysis.</p><p>In the section of &#x0201c;Genes for (2R)-methoxymalonyl-ACP biosynthesis&#x0201d;, line 381-382, tautomycin and oxazolomycin are suggested to be referred as well.</p><p>Fig 9: It is more appropriate to remove Fig 9 to supporting information.</p><p>S13 Fig: more PyrE3 homologues are suggested to be subjected to phylogenetic analysis.</p><p>Line 987: &#x0201c;Fig Alignment of&#x0201d; should be &#x0201c;S14 Fig Alignment of&#x0201d; The accession numbers of protein sequences for alignment are suggested to be added.</p><p>Please number all the compounds in the manuscript.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p><p>Reviewer #1: No</p><p>Reviewer #2: No</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article id="pone.0239054.r002" article-type="author-comment"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0239054.r002</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pone.0239054" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">3 Jul 2020</named-content>
</p><p>Please see attached .pdf document for our response.</p><supplementary-material content-type="local-data" id="pone.0239054.s020"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to reviewers.pdf</named-content></p></caption><media xlink:href="pone.0239054.s020.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article id="pone.0239054.r003" article-type="editor-report"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0239054.r003</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cirino</surname><given-names>Patrick C.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Patrick C. Cirino</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Patrick C. Cirino</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pone.0239054" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">31 Aug 2020</named-content>
</p><p>The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic.</p><p>PONE-D-20-10863R1</p><p>Dear Dr. Little,</p><p>We&#x02019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#x02019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x02019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x02019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p><p>Kind regards,</p><p>Patrick C. Cirino</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>Reviewers' comments:</p></body></sub-article><sub-article id="pone.0239054.r004" article-type="editor-report"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0239054.r004</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cirino</surname><given-names>Patrick C.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2020 Patrick C. Cirino</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Patrick C. Cirino</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pone.0239054" related-article-type="reviewed-article"/></front-stub><body><p>
<named-content content-type="letter-date">3 Sep 2020</named-content>
</p><p>PONE-D-20-10863R1 </p><p>The biosynthetic pathway to tetromadurin (SF2487/A80577),
a polyether tetronate antibiotic </p><p>Dear Dr. Little:</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p><p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p><p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p><p>Thank you for submitting your work to PLOS ONE and supporting open access. </p><p>Kind regards, </p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Patrick C. Cirino </p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article>